Contents
Welcome Message … …………………………………………………………… 3
Committee Members …………………………………………………………… 4
Access … ………………………………………………………………………… 5
Schedule … ……………………………………………………………………… 6
Floor Plan ………………………………………………………………………… 9
General Information … ………………………………………………………… 10
Information for Chairs and Speakers … ……………………………………… 12
Award and Social Programs … ………………………………………………… 15
Acknowledgements … ………………………………………………………… 16

Lecture … ……………………………………………………………………… 17
Guideline … …………………………………………………………………… 34
Symposium … ………………………………………………………………… 36
Oral Session … ………………………………………………………………… 64
Moderated Poster … ………………………………………………………… 68
Free Poster … ………………………………………………………………… 71
Luncheon Seminar … ………………………………………………………… 76
Hands-on Seminar / Presidential Seminar … ……………………………… 77

Index ……………………………………………………………………………… 80

Welcome Message

Dear Colleagues!
On behalf of the Organizing Committee, it is our great pleasure to welcome you to the 13th International
Symposium on Urolithiasis (ISU2016) to be held in Makuhari, Japan from July 19th to 22nd, 2016.
ISU2016 is the thirteenth symposium in a series of international symposia which started in Leeds, UK in
1968 and which have been subsequently held every four years in different parts of the world.
The Program Committee of ISU2016 have selected the most intriguing topics on urolithiasis research andclinical aspects of stone disease. Scientists and physicians of different specialties and fields from all over
the world will meet to exchange new ideas and knowledge in the history, metaphylaxis, epidemiology,
pathogenesis, diagnosis and medical/surgical management of urinary stones.
There will be 12 keynote lectures and 10 symposia delivered by international faculty and distinguishedleaders in this field. Guideline lectures will be given by AUA and EAU faculties. Hands-on seminar on
endourology will be scheduled during the congress period.
Makuhari is conveniently located between Narita International Airport and Haneda Airport. Only 20
minutes away is the Tokyo Disney Resort, the world-famous theme park. You can visit traditional andhistorical places through Tokyo station, the gateway of Japan, which is just 30 minutes away by train.
We hope you will get new insights and innovations at this meeting and enjoy your stay in Makuhari!
Sincerely yours,

Tomohiko Ichikawa, M.D., Ph.D.

Katsuhito Miyazawa, M.D., Ph.D.

Congress President

Co-Congress President－3－13th International Symposium on Urolithiasis

Committee Members
Honorary President
Koji Suzuki, Japan

Congress President
13th International Symposium on Urolithiasis
Tomohiko Ichikawa, Japan

Co-Congress President
13th International Symposium on Urolithiasis
Katsuhito Miyazawa, Japan

Congress President
26th Annual Meeting of Japanese Society on Urolithiasis Research
Yukio Naya, Japan

Steering Committee
Walter L. Strohmaier, Germany

Alberto Trinchieri, Italy

Rosemary L. Ryall, Australia

Philippe Jaeger, UK

William G. Robertson, UK

Nestor Schor, Brazil

Allen L. Rodgers, South Africa

Marguerite Hatch, USA

Hans-Göran Tiselius, Sweden

Saeed R. Khan, USA

Glenn M. Preminger, USA

Kemal Sarica, Turky

Fazil Y. Marickar, India

Katsuhito Miyazawa, Japan

Local Organizing Committee◆ Finance Committee◆ PR Committee

Chairman: Isao Hara, Japan

Chairman: Takahiro Yasui, Japan

Member: Yasuo Kohjimoto, Japan

Member: Atsushi Okada, Japan

Satoshi Yamaguchi, Japan◆ Program Committee
Chairman: Tatsuya Nakatani, Japan◆ International Committee
Chairman: Kikuo Nutahara, Japan

Member: Taro Iguchi, Japan
Shinichi Sakamoto, Japan
Nobuyo Morita, Japan◆ Exhibition Committee
Chairman: Takashi Arakawa, Japan◆ Audit Committee
Member: Keiichi Tozawa, Japan
Motoyuki Masai, Japan－4－

ISU2016

Access－5－

13th International Symposium on Urolithiasis

Schedule－6－

ISU2016

Schedule－7－

13th International Symposium on Urolithiasis

Schedule－8－

ISU2016

Floor Plan

－9－

13th International Symposium on Urolithiasis

General Information
OutlineDate：Tuesday 19th - Friday 22nd July, 2016
Venue：Makuhari Messe

2-1, Nakase, Mihama-ku, Chiba-city, 261-8550 Japan

Secretariat：c/o Congress Corporation
Kohsai-kaikan Bldg., 5-1 Kojimachi, Chiyoda-ku, Tokyo, 102-8481 Japan
Official Website：http://www.congre.co.jp/isu2016/index.html

Registration Desk
The on-site registration desk will be located on the 1st floor of the International Conference Hall.
Opening hours are as follows:
・Tuesday, 19th July :8:00 - 16:30

・Wednesday, 20th July : 8:00 - 16:30
・Thursday, 21st July :8:30 - 16:00

・Friday, 22nd July :8:30 - 10:00

Registration
REGISTRATION CATEGORIES

ON-SITE REGISTRATION

Doctor

JPY 50,000

Resident*

JPY 20,000

Medical staff / Student*

JPY 10,000

One day**

JPY 15,000

Accompanying Person***JPY 15,000

Important:
Payments must be made by Japanese Yen (credit card is available).
*The reduced registration fee for Resident, Student, Medical staff are only granted if appropriate certificate or
identification card is provided at registration desk. Certificate format is available on official website.
**One day fee allows attending ISU2016/JSUR2016 for just one day and you can select the day of your preference.
***Accompanying Person can access exhibition area, but registration of Accompanying Person does not include
access to scientific programs.

Badge Identification
A name badge is provided at registration desk. For security and regulation purposes, the wearing of thebadge is compulsory at all times both inside Makuhari Messe and at all official events organized within
the context of the congress.

Registration Cancellation Policy
No refund will be issued for cancellations received on or after Friday, 1st June, 2016 (JST) or for no-shows.

Abstracts
Abstracts are published online (supplement issue of Urolithiasis).
You can access SpringerLink through ISU2016 official website and find the abstracts for free from Friday,
1st July to Wednesday, 31st August.
Note: It will no longer be free to access the supplement issue after Thursday, 1st September.
－ 10 －

ISU2016

Certificate of Attendance
A certificate of attendance will be printed and given to all the participants together with your name badge
at the registration desk.

Exhibition
Venue: Convention Hall A
Opening hours are as follows:
・Tuesday, 19th July :9:00 - 18:45
・Wednesday, 20th July : 9:00 - 18:00
・Thursday, 21st July : 9:00 - 18:02

Tea & Coffee
Tea and Coffee will be available to participants at the following hours and dates at Convention Hall A.
・Tuesday, 19th July :14:50 - 15:10
・Wednesday, 20th July : 15:00 - 15:20
・Thursday, 21st July : 15:30 - 15:40

Lunches and Doughnuts
Lunch boxes will be provided at all Luncheon Seminars without any charge.
Lunch boxes will be provided on a first come first served basis: please note that they are in limited supply.
Before the sessions on 20th~22nd morning, doughnuts will be served at the lobby on the 2nd floor.

Hands-on Seminar
In parallel with the scientific program, hands-on seminar will be held on Thursday, 21st July at 202.
Hands-on seminar needs pre-registration. Please access official website for detailed information.

Rules and Restrictions in the Venue
・It is prohibited to photograph, film or record the presentations and lectures of the Symposium.
・The venue is a non-smoking area. Please smoke only at the designated smoking areas.
・Please be sure to switch off all mobile phones or set them on silent mode upon entering the venue.

Cloakroom
A cloakroom is located on the 1st floor. Please make sure that no personal belongings are left after
sessions closing each day.
Opening hours are as follows:
・Tuesday, 19th July :8:00 - 19:00
・Wednesday, 20th July : 8:00 - 19:15
・Thursday, 21st July : 8:30 - 18:15
・Friday, 22nd July :8:30 - 11:15

Internet Access
The Congress organizers have made available to the participants a Wi-Fi access. This access is free ofcharge and will be provided for the duration of the event.

Lost and Found
Lost items should be returned to the General Information Desk which is located on the 1st floor. Should
you lose anything, please report to this desk for assistance.

－ 11 －

13th International Symposium on Urolithiasis

Information for Chairs and Speakers
Guidelines for Chairs
1. Please take a seat in the front row of the room specially reserved for the next session's chair, at least
10 minutes prior to the session that he/she is scheduled to chair.
* For chairs of Moderated poster: Please come to Cheek-in Desk for chairs of Moderated poster in theConvention Hall A at least 10 minutes prior to your session.
2. As there will be no announcement or cue, please proceed to take the stage promptly at the appointed
time and initiate the session. We request for your cooperation to ensure that your session proceeds
according to the prescribed time limit/schedule.

Disclosure of Conflict of Interest (COI)
All oral and poster presentations are required to show a slide disclosing any potential conflicts of interest.
For oral presentation, please insert the COI slide in the second page of your presentation slides. For poster
presentation, please place the COI slide at the bottom right of the poster panel. Please download the COI
slide templates for the disclosures from the ISU2016 official website.

Guidelines for Speakers of Oral Presentation
1. All presentation must be made in the form of PC presentation in English.
2. Presentation timekeeping- Please be punctual and carefully follow the allotted time limits.
- Illuminating orange lamp indicates one minute remaining and red lamp indicates the end of yourpresentation.
3. Next Speaker’s seat
- When the presenter ahead of you takes the stage, please be seated in the Next Speaker’s seat.
4. Notes on preparing your presentation data
- The resolution of the screen will be XGA (1024 × 768).
- Use only the standard fonts provided with Microsoft PowerPoint for Windows.
- Virus scanning in advance is desirable.
- Prepare your presentation on USB memory or on CD-R. Do not use CD-RW.
- Save your slides as a Microsoft7 or later for Windows file (ex.2003, 2007, 2010, 2013).
- Be sure that your file is compatible with Windows operation system.
- Sound cannot be used.
5. Notes for speakers with their own PC- Remember to bring your own power adaptor and cables.
- Your computer must be equipped with a Dsub-15 pin video output .
(Thin PCs may not have standard output terminals.)

Dsub-15 pin video output－ 12 －

ISU2016- Please prepare your slides with Microsoft PowerPoint.
- The PCs prepared by the secretariat will handle Windows and Macintosh versions of Microsoft
PowerPoint only.
- Please avoid using KeyNote.
- In case of that you cannot connect to the projector provided by the secretariat, please bring a backup
CD-R or USB memory containing the presentation file in a Windows or Macintosh version of Microsoft
PowerPoint.
- Presenters are responsible for determining in advance whether their laptop PC is capable of outputting
video to an external display. This is especially important your presentation contains a large amount ofdata and audiovisual content.
- All energy-conserving functions such as screen-savers, sleep/power-saving modes should be disabledon PCs to be used in the presentation.
- Your password also should be inactivated.
6. Presentation file reception and presentation format- Speakers should preview their presentation and complete a run-through of the connection and operation
at the speakers preview center in front of the Room1 (International Conference Room) on the 2nd floor of
the International Conference Hall, at least 60 minutes before their sessions start or 30 minutes before if
their sessions are scheduled in the first session of the day.
- Staff will be on hand at the speakers preview center to assist speakers.
- The speaker's podium is equipped with a PC. Speakers are asked to operate during the presentationby themselves.
- After ISU2016, all presentation data installed on the secretariat supplied PCs will be deleted.
[Speakers preview center]
Opening hours:
・Tuesday 19th July :8:00 - 16:30

・Wednesday 20th July : 8:00 - 16:30
・Thursday 21st July :8:30 - 16:00

・Friday 22nd July :8:30 - 10:00

Guidelines for Speakers of Moderated Poster and Free Poster
Venue: Convention Hall A
1. Poster Materials should be prepared in English.
- Presentation time for Moderated poster will be 3 minutes and discussion time will be 3 minutes.
- Poster presenters are expected to stand ready in front of their poster panels during the scheduled
presentation time and discussion time with the presenter's ribbon on their chests, and to havepresentation and discussion with other participants.
- All poster boards will be assigned with a number which corresponds to poster number.
- Authors are required to mount their posters on the designated board and remove them during the time
specified below.
- Please use push-pins to affix your poster to the board firmly.
- Any poster left after the scheduled removal time will be discarded by the Secretariat.

－ 13 －

13th International Symposium on Urolithiasis

2. Poster setup, presentation and discussion, and removal schedule
Setup
Presentation&
Discussion
RemovalPush-pins will be provided by thesecretariat.

19th July, 9:00-10:00
Moderated Poster
21st July, 16:50-18:02
Free Poster (Discussion only)
19th July, 17:30-18:30

Please be ready in front of your poster
panel to have presentation anddiscussions with other participants.
Posters not removed by 19:00 on 21st
July will be discarded by the secretariat.

21st July, 18:02-19:00

3. The size of the poster board is 900mm wide by 2,100mm high.
Please prepare your poster in accordance with the figure below.

－ 14 －

ISU2016

Award and Social Programs
Commendation for Lifetime Achievement Award
Thursday, 21st July: 15:00-15:30
Makuhari Messe, International Conference hall 2F Room1 “International Conference room”
Awardees:
Hans-Göran Tiselius (Karolinska Institutet)
Saeed R. Khan (Department of Pathology, Department of Urology, College of Medicine, University of Florida)

Welcome Reception
Tuesday, 19th July : 17:15-18:45
Makuhari Messe, International Conference hall 2F “Convention Hall A”(Included in the registration fees)

Gala DinnerThursday, 21st July : 18:45-20:45
HOTEL THE Manhattan, “PRIMAVERA”(Ticketed event: Please bring the ticket.)－ 15 －

13th International Symposium on Urolithiasis

13th International Symposium on Urolithiasis (ISU2016)
26th Annual Meeting of Japanese Society on Urolithiasis Research (JSUR2016)

Acknowledgements
Supporting Organizations
The Japanese Urological Association
Japanese Society of Endourology

Foundations
The Uehara Memorial Foundation
Suzuki Foundation for Urological Medicine
Chiba Convention Bureau and International Center (CCB-IC)
The Tokyo Biochemical Resarch Foundation
The Naito Foundation

Gold Sponsor

Exhibitors/Sponsored Seminars/Advertisements/Contributions
ASAHI KASEI PHARMA CORPORATION
Astellas Pharma Inc.
AstraZeneca K.K.
Bayer Yakuhin, Ltd
B. Braun Aesculap Japan Co. Ltd.
Boston Scientific Japan K. K.
CENTRAL MEDICAL Co., Ltd.
COLOPLAST PORGES
Covidien Japan Inc.
CSL Behring K.K.
DAIICHI SANKYO COMPANY, LIMITED.
DIREX Japan Co., Ltd.
Dornier MedTech Japan Co., Ltd.
EDAPTECHNOMED Co., Ltd.
FUJIFILM Medical Co., Ltd.
GlaxoSmithKline K.K.
INNOMEDICS Medical Instruments Inc.
ISO MEDICAL SYSTEMS INC.
Janssen Pharmaceutical K.K.
Johnson & Johnson K.K.
KISSEI PHARMACEUTICAL CO., LTD.

KYORIN Pharmaceutical Co., Ltd.
KYOWA HAKKO BIO CO., LTD.
KYSMAQ CO., LTD.
Medicon, Inc.
MM CORPORATION
Nippon Chemiphar Co., Ltd.
Nippon Kayaku Co., LTD.
Nippon Shinyaku Co., Ltd.
Novartis Pharma K.K.
Otsuka Pharmaceutical Co., Ltd.
Pfizer Japan Inc.
Sanofi K.K.
SANWA KAGAKU KENKYUSHO CO., LTD.
Shigaku Shoten
SUMIRE MEDICAL CORPORATIONTAIHO PHARMACEUTICAL CO., LTD.
Takai Hospital Supply Co,. Ltd.
Takeda Pharmaceutical Company Limited.
TAKEI IKAKOUKI Co., Ltd.
TEIJIN PHARMA LIMITED.
Tomiki Medical Instruments Co., Ltd.
As of 22nd June, 2016
－ 16 －

ISU2016

L-01

Extracorporeal shock wave lithotripsy (ESWL)
July 19 (Tue)9:00-9:30

Room 1（2F International Conference Room）

Chair
Tadashi Matsuda
Kansai Medical University, Japan
Dr. Tadashi Matsuda graduated from Kyoto University School of Medicine in 1978,
and is Professor and Chairman of the Department of Urology and Andrology, Kansai
Medical University, Japan since 1995. He is currently Vice Dean of the university, andVice Director of Kansai Medical University Hirakata Hospital. Dr. Matsuda has contributed to the field of
endourology and urologic laparoscopy. He served as the President of the Japanese Society of Endourology,
and the President of the Local Organizing Committee of 29th World Congress of Endourology and SWL
held in 2011 at Kyoto, Japan. He is now the President of the Endourological Society. He is an International
Member of the American Association of Genitourinary Surgeons.

Speaker
Christian G. Chaussy
University of Regensburg, Germany
Treated after 6 years of intensive pre-clinical research at the University of Munich on
February 7th 1980 the first patient worldwide with ESWL. From 1984 – 1986 he wasProfessor of Urology and Head of the Stone Center at UCLA, left this tenure position in1986 to become Chairman of the Department of Urology Klinikum Harlaching in Munich from which heretired in 2010. 1996 he had started the use of HIFU for the treatment of localized Prostate Cancer. 2011
he was President of the Endourological Society. Besides his Professorship in Munich he is currently holding
positions as Consultant Professor at the Department of Urology, University of Regensburg and as Clinical
Professor of Urology at the Keck School of Medicine, USC.

－ 17 －

LectureLecture 1

13th International Symposium on Urolithiasis

Lecture 2
LectureL-02

Residual fragments: definition, evaluation and management
July 19 (Tue)

9:30-10:00

Room 1（2F International Conference Room）

Chair
Tomohiko Ichikawa
Department of Urology, Graduate School of Medicine, Chiba University, Japan
1984
1989
1989199119921997199820012004-

M.D., Chiba University, Chiba, Japan
Ph.D. (Doctor of Medical Science), Chiba University
Postdoctoral Fellow, Johns Hopkins Oncology Center, Baltimore, MD
Clinical Fellow, Department of Urology, Chiba University Hospital
Assistant Professor, Department of Urology, School of Medicine, Chiba University
Assistant Professor, Department of Urology, Teikyo University School of Medicine, Ichihara Hospital
Assistant Professor, Department of Urology, School of Medicine, Chiba University
Associate Professor, Department of Urology, Graduate School of Medicine, Chiba University
Professor and Chairman, Department of Urology, Graduate School of Medicine, Chiba University

2014- President: Japan Society of Andrology
2014- President: Japanese Society of Urolithiasis Research
2013- Board of directors: The Japanese Urological Association－ 18 －

ISU2016

Kemal Sarica
Department of Urology, Dr. Lutfi KIRDAR Research and Training Hospital, Turkey
Graduated Faculty & Year: University of Ankara, Medical School, 1981
Place & Date of Professorship: University of Gaziantep, Medical School,
Dept. of Urology, 2003
Professional Publications (215)
Number of Books/Book Chapters: 9
Memberships in Associations• American Urological Association (AUA)• European Urological Association (EAU)• Endourological Society• Eurolithiasis Society (EULIS)International positions in Associations• Chairman : EAU Section of Eurolithiasis (EULIS)• Member, Urolithiasis Guidelines Committee (EAU)• Member , International Urolithiasis Society board (IUS)• Co-chairman International Alliance of Urolithiasis (IAU)
Member ( Editorial board, International journals )Urological Research (Member, editorial board)Archiv.Italian.Urol.Androl (Member, editorial board)－ 19 －

LectureSpeaker

13th International Symposium on Urolithiasis

Lecture 3
LectureL-03

Urinary risk factors for urolithiasis
July 19 (Tue)

14:20-14:50

Room 1（2F International Conference Room）

Chair
Koji Suzuki
Kanazawa Medical University, JapanPRESENT APPOINTMENT:
Professor Emeritus,
Department of Urology, Kanazawa Medical University
Uchinada, Ishikawa, 920-0293, JapanDATE AND PLACE OF BIRTH:
15th Nov 1947, Nara, JapanNATIONALITY: Japanese
UNIVERSITY; Kanazawa University, Japan
DEGREES: M.D., Ph.D.
PREVIOUS EXPERIENCE:
1974-1990
Department of Urology, Kanazawa Medical University
1990-1991
Department of Surgery, Flinders Medical Centre
1991-2013
Department of Urology, Kanazawa Medical University(Chairman and Professor)
2013-present Professor Emeritus, Kanazawa Medical University
MEMBERSHIP: International Symposium on Urolithiasis
The Société Internationale d'Urologie
American Urological Association
Japanese Urological Association
Japanese Society on Urolithiasis Research
Japanese Society of Endourology
EDITORIAL AND JOURNAL REVIEW EXPERIENCE:
2003-2012 Associate Editor, Urological Research (Urolithiasis)
ORGANIZATIONAL EXPERIENCE:
1999, 2005 Chair, Japanese Society on Urolithiasis Research
2000-2008 Member, International Organizing Committee,
International Symposium on Urolithiasis
2008-2011 President, Japanese Society on Urolithiasis Research－ 20 －

ISU2016

William G. Robertson
Nuffield Department of Surgical Sciences, John Radcliffe Hospital, University of Oxford,UK
I have been working on the causes and medical management of kidney stones for over
50 years with particular research interests in the chemical, biochemical, epidemiological,
environmental, lifestyle, nutritional and metabolic factors involved in the initiation of renal stone-formation.
Based on these findings, I have developed a comprehensive screening system for assessing a given patient's
risk of forming further stones (LITHOSCREEN) which I have been using to manage patients for the past 15
years and which complies completely with the latest AUA Guidelines on the management of patients withkidney stones. LITHOSCREEN also allows me to design an appropriate preventative treatment tailored tothe particular risk factors identified in each patient. I am also Editor-in-Chief of Urolithiasis, which is the
only journal specialising in all aspects of stone research.

－ 21 －

LectureSpeaker

13th International Symposium on Urolithiasis

Lecture 4
LectureL-04

Overview of endourology
July 20 (Wed)9:00-9:30

Room 1（2F International Conference Room）

Chair
Kikuo Nutahara
Department of Urology, Kyorin University School of Medicine, Japan
Dr. Kikuo Nutahara graduated from Iwate Medical University School of Medicine in
1978. Since 2013, he has been Professor and Chairman of Department of Urology,
Kyorin University School of Medicine, Tokyo, Japan. He has contributed in the field of
endourology and Ca metabolism. He served as a chairman of Japanese Society of Endourology in 2015.
He is now a member of the Board of Directors of Japanese Society of Endourology, Japanese Society on
Urolithiasis Research, and one of the Delegates of Endourological Society.

SpeakerWalter L. Strohmaier
Klinikum Coburg, Germany
Born in 1957, graduated at the University of Tübingen in 1983. German board
certification in 1989. In 1992, Assistant Professor at the University Tübingen andEuropean Board of Urology certification. Since 1996, Head of the Department of Urology
and Paediatric Urology, Klinikum Coburg, Academic Hospital, University of Würzburg. Since 1998, Full
Professor of Urology, since 2001 Medical Director of Klinikum Coburg.
His scientific work with focus on all aspects of urolithiasis (265 publications, 620 lectures) was honoured
by several awards. In 2005, he organized the 11th European Symposium on Urolithiasis. He is chairmanof the International Urolithiasis Society, vice-chairman of the guideline panel of the German Association of
Urology.
He is Associate Editor of Urolithiasis, reviewing editor of Urologia Internationalis and peer reviewer for all
major international urological journals.

－ 22 －

ISU2016

L-05

Cystinuria: genomic characteristics in Japan
July 20 (Wed)

9:30-10:00

Room 1（2F International Conference Room）

Chair
Tatsuya Nakatani
Osaka City University Graduate School of Medicine, Japan
Osaka City University Graduate School of Medicine(Ph.D.,1983)
Apr-1999: Associate Professor oh Department of Urology, Osaka City University Graduate
School of Medicine
Apr-2003: Professor and Chairman of Department of Urology, Osaka City University Graduate School of
Medicine

Speaker
Tomohiko Ichikawa
Department of Urology, Graduate School of Medicine, Chiba University, Japan
1984
1989
1989199119921997199820012004-

M.D., Chiba University, Chiba, Japan
Ph.D. (Doctor of Medical Science), Chiba University
Postdoctoral Fellow, Johns Hopkins Oncology Center, Baltimore, MD
Clinical Fellow, Department of Urology, Chiba University Hospital
Assistant Professor, Department of Urology, School of Medicine, Chiba University
Assistant Professor, Department of Urology, Teikyo University School of Medicine, Ichihara Hospital
Assistant Professor, Department of Urology, School of Medicine, Chiba University
Associate Professor, Department of Urology, Graduate School of Medicine, Chiba University
Professor and Chairman, Department of Urology, Graduate School of Medicine, Chiba University

2014- President: Japan Society of Andrology
2014- President: Japanese Society of Urolithiasis Research
2013- Board of directors: The Japanese Urological Association－ 23 －

LectureLecture 5

13th International Symposium on Urolithiasis

Lecture 6
Lecture

L-06

Transporter and urolithiasis
July 20 (Wed)

13:30-14:00

Room 1（2F International Conference Room）

Chair
Tomohiko Ichikawa
Department of Urology, Graduate School of Medicine, Chiba University, Japan
1984
1989
1989199119921997199820012004-

M.D., Chiba University, Chiba, Japan
Ph.D. (Doctor of Medical Science), Chiba University
Postdoctoral Fellow, Johns Hopkins Oncology Center, Baltimore, MD
Clinical Fellow, Department of Urology, Chiba University Hospital
Assistant Professor, Department of Urology, School of Medicine, Chiba University
Assistant Professor, Department of Urology, Teikyo University School of Medicine, Ichihara Hospital
Assistant Professor, Department of Urology, School of Medicine, Chiba University
Associate Professor, Department of Urology, Graduate School of Medicine, Chiba University
Professor and Chairman, Department of Urology, Graduate School of Medicine, Chiba University

2014- President: Japan Society of Andrology
2014- President: Japanese Society of Urolithiasis Research
2013- Board of directors: The Japanese Urological Association

Speaker
Yoshikatsu Kanai
Osaka University Graduate School of Medicine, Japan
Yoshikatsu Kanai, M.D., Ph.D. is Professor of Osaka University Graduate School of
Medicine, Osaka, Japan. He graduated form Gunma University School of Medicine(Maebashi, Japan) in 1984 and Graduate School of Medicine, University of Tokyo (Tokyo,
Japan) in 1988. He worked as a research associate in Renal Division at Brigham and Women's Hospitaland Harvard Medical School (Boston, U.S.A.) and then promoted as Professor of Pharmacology in Kyorin
University School of Medicine (Tokyo, Japan) in 2004. He moved to Osaka University as Professor of Biosystem Pharmacology in 2007. He has worked on molecular identification of many types of transportersthat include renal cysitne transporter whose genetic defect is the cause of cystinuria. Recently, his researchhas extended to the unsolved basic issues related to renal cystine transport and cystinuria.

－ 24 －

ISU2016

L-07

Animal models for study of calcium oxalate nephrolithiasis:
lessons learned
July 20 (Wed)14:00-14:30

Room 1（2F International Conference Room）

Chair
Makoto Morozumi
Department of Urology, Saitama Medical Center/Saitama Medical University, Japan1982
Graduation of School of Medicine, University of Tsukuba
1982
M.D. (Japan Board of Medical Examiners: No.265815 )1982
Resident, School of Medicine, Juntendo University
1982-83
Assistant of Urology, School of Medicine, Juntendo University
1984 Jan-Jun
Urologist, Mito Saisei-kai Hospital
1984 Jul-Dec
Urologist, Mitsui Memorial Hospital
1985-1986
Assistant of Urology, School of Medicine, Juntendo University
1986-1987 Jun Urologist, Doai Memorial Hospital
1987 July-1995 Urologist, Koshigaya Municipal Hospital
1995
Ph.D. (Juntendo University: No. 1216)
1995-2000
Chief of Urology, Koshigaya Municipal Hospital
1997-2000
Assistant Professor of Urology, School of Medicine, Juntendo University
2001-2003
Assistant Professor of Urology, Faculty of Medicine, University of the Ryukyus
2003-2004
Visiting Assistant Professor, Department of Pathology, University of Florida
2004-2005
Assistant Professor of Urology, Faculty of Medicine, University of the Ryukyus
2006Associate Professor of Urology, Saitama Medical Center, Saitama Medical University

Speaker
Saeed R. Khan
Department of Pathology, Department of Urology, College of Medicine, University of
Florida, USA
Saeed R Khan is Finlayson Professor of Urological Research in the Department ofUrology, University of Florida and Director of their Training Program in Benign Urology
Research. He is Associate Editor of Urolithiasis. Dr. Khan investigates all aspects of stone disease using
experimental models as well as clinical specimens. His research has been supported by US National
Institutes of Health. He has mentored over thirty graduate students and twenty post-doctoral fellows,
authored more than four hundred publications including refereed articles in peer reviewed journals, bookchapters, editorials, review articles and numerous abstracts. He has also edited a book, Oxalate in Biological
Systems as well as Proceedings of the International Symposia. He has participated in numerous national
and international meetings, giving more than seventy invited lectures and keynote addresses.
－ 25 －

LectureLecture 7

13th International Symposium on Urolithiasis

Lecture 8
LectureL-08

The role of fluid intake in the recurrence prevention ofurinary stones
July 20 (Wed)

14:30-15:00

Room 1（2F International Conference Room）

Chair
Bernhard Hess
Internal Medicine and Nephrology, Kidney Stone Center Zurich, Klinik Im Park, Zurich,
Switzerland
1972-1978 : Medical School Zurich.
1980 : M.D. degree, Faculty of Medicine, Zurich.
1980-1981 Pathology, Liestal/Basle
1981-1989 Internal Medicine and Nephrology in Zurich and Chicago
1989-1999: Chief-Resident and Chief ai of General Internal Medicine, University HospitalBerne
1994 Associate Professor Nephrology, University of Berne
1999-2005: Chief of Internal Medicine, Hospital Zimmerberg, Waedenswil/Zurich
2002 Associate Professor Internal Medicine, University of Zurich
7/2005- : Internal Medicine and Nephrology, Hirslanden Klinik Im Park Zurich and Paracelsus
Hospital Richterswil/Zurich, Switzerland
Founder/Chief of Kidney Stone Center Zurich
Nationally/internationally 700 lectures/workshops.
More than 150 scientific papers/reviews/book chapters.
Grant recipient for research on idiopathic calcium nephrolithiasis
Member of Editorial Board of Urolithiasis, regular reviewer for nephrology and urology journals worldwide
Honorary Member of Swiss Society of Urology, former executive member of eULIS (Eurolithiasis Society,part of EAU)

－ 26 －

ISU2016

Roswitha Siener
University Stone Centre, Department of Urology, University of Bonn, Germany
Prof. Dr. Roswitha Siener is a Professor in the Department of Urology at the Universityof Bonn, Germany, and Head of the University Stone Centre. Areas of her research arenearly all aspects of urinary stone disease, including epidemiology, pathophysiology,
metabolism and nutrition.
Prof. Siener has authored numerous peer-reviewed articles, book chapters and conference abstracts. She
has received several scientific awards both nationally and internationally. Prof. Siener is Editorial board
member of the Journal of Translational Medicine, Urolithiasis and Uro-News and board member of theEuropean Association of Urology (EAU) section of urolithiasis (EULIS).

－ 27 －

LectureSpeaker

13th International Symposium on Urolithiasis

Lecture 9
LectureL-09

Role of race, ethnicity and environmental factors
July 21 (Thu)

9:00-9:30

Room 1（2F International Conference Room）

Chair
Kenjiro Kohri
Nagoya City University, Japan
Education
MD Osaka University Medical School
PhD Osaka University Medical School
Research & Professional Experience
Resident of Anesthesiology Osaka Univ Hospital
Urologist Higashi-Osaka City Hospital
Assistant Dept Urology, Kinki Univ Med Sch
Lecture Dept Urology, Kinki Univ Med Sch
Postdoctoral fellow for JSPS and Exchange fellow of British Royal Society Dept
Urology, South Manchester University
Professor Dept Urology, Nagoya City Univ Med Sch
President Nagoya City Univ Hospital
Professor Dept Nephro-Urology, Nagoya City Univ Grad Sc Med Sci
Dean Nagoya City Univ Grad Sc Med Sci
President Nagoya City Univ

Speaker
Allen L. Rodgers
University of Cape Town, South Africa
Allen Rodgers MSc, PhD is currently Emeritus Professor & Senior Research Scholar at
the University of Cape Town, South Africa, a position which he has held since January
2012. Prior to this he was Professor and Head of the Department of Chemistry for 11
years. He is a Life-time Fellow of the University of Cape Town and a Fellow of the Royal Society of South
Africa. His research focus for the past 35 years has been the physicochemical aspects of calcium kidneystone disease, a field in which he has published over 150 articles in peer-reviewed papers, conference
proceedings and abstracts. He has trained 15 PhD and 12 MSc students. He is an Associate Editor of
Urolithiasis and has served on the advisory boards of many international conferences on Urolithiasis.

－ 28 －

ISU2016

L-10

Randall's plaques versus ductal plugs as sites of theearliest growth of kidney stones
July 21 (Thu)

9:30-10:00

Room 1（2F International Conference Room）

Chair
Philippe Jaeger
University College of London, Centre for Nephrology, London, UK
Professor Philippe Jaeger: Swiss Internist and Nephrologist holding an Honorary Chairof Nephrology at University College of London, UK.
Currently: Invited Professor and Scientific Adviser at Geneva University, Switzerland; Honorary Presidentof the Fondation du Rein; Vice-President of the Foundation for the Development of Internal Medicine inEurope; Founding Member of the European Federation of Internal Medicine.
In the past: Chairman of Ambulatory Medicine at Berne University, Switzerland; Chairman of Nephrology at
Nice University, France; Director Research & Development Nephrology at Amgen International in London,
UK; President of Swiss Society of Internal Medicine, French Society of Nephrology, European Federation ofInternal Medicine, Fondation du Rein.
Trained in nephrology at Yale University (USA). Current research activity focused on Nephrolithiasis.
Excellence in education has been the primary objective of his academic career.

SpeakerJames C. Williams
Indiana University School of Medicine, USA
James Williams is Professor of Anatomy and Cell Biology at the Indiana University Schoolof Medicine in Indianapolis, USA, and Adjunct Professor of Urology, University of Southern
Denmark, in Odense. His primary area of research is in understanding urinary stonediseases. Recent studies have revealed that some calcium oxalate stone formers produce stones solely on
Randall's plaque (interstitial, white plaque), while others also produce plugging of collecting ducts in the renal
papilla. Visualization of these distinct mechanisms (interstitial plaque formation versus ductal plugging) has
required study of the structure of the tiny stones that were found growing on the renal papillae in patients.
This characterization of these stones has been possible only because of the development of micro-computed
tomographic (micro CT) imaging of stones, work begun in Prof. Williams' laboratory.

－ 29 －

LectureLecture 10

13th International Symposium on Urolithiasis

Lecture 11
LectureL-11

The primordial protein: macromolecules, minerals andrenal stones
July 21 (Thu)

14:30-15:00

Room 1（2F International Conference Room）

Chair
Katsuhito Miyazawa
Kanazawa Medical University, JapanPRESENT APPOINTMENT:			
Professor and Chairman
			Department of Urology, Kanazawa Medical University
			
Uchinada, Ishikawa, 920-0293, JapanDATE AND PLACE OF BIRTH:			
20th Dec 1959, Ishikawa, JapanNATIONALITY: 		
Japanese
UNIVERSITY;		
Kanazawa Medical University, Japan
DEGREES: 		
M.D., Ph.D.
PREVIOUS EXPERIENCE:
1984-1999
Department of Urology, Kanazawa Medical University
1999-2000
Department of Surgery, Flinders Medical Centre
2000- present Department of Urology, Kanazawa Medical University
2011- present Professor, Kanazawa Medical University
MEMBERSHIP: International Symposium on Urolithiasis
			The Société Internationale d'Urologie			Endourological Society			American Urological Association
			Japanese Urological Association
			Japanese Society on Urolithiasis Research			Japanese Society of Endourology
EDITORIAL AND JOURNAL REVIEW EXPERIENCE:
2012- present Associate Editor, Urolithiasis (Urological Research)
2013- present Editorial Board, International Journal of Urology
ORGANIZATIONAL EXPERIENCE:
2008- present Member, International Organizing Committee,
			International Symposium on Urolithiasis－ 30 －

ISU2016

LectureSpeaker
Rosemary L. Ryall
Flinders University, Australia
Professor Emeritus Rosemary Ryall was Chief Medical Scientist and Professor of UrologicalResearch in the Department of Surgery at the Flinders Medical Centre and Flinders
University, South Australia.
Forty years ago Rose began investigating biochemical factors affecting the development of kidney stones,
especially those influencing the crystallization of calcium oxalate. Her interests later evolved to studying
the involvement of urinary macromolecules, principally proteins, in the process. Believing that theunderstanding of pathological events is illuminated by knowledge of salubrious counterparts in nature, Rose
has long advocated the need for stone researchers to learn from examples of healthy biomineralization,
which occurs in countless organisms throughout the evolutionary tree.
At the previous International Symposium on Urolithiasis in Brazil she received a Birdwell Finlayson Lifetime
Achievement Award for her stone research.

－ 31 －

13th International Symposium on Urolithiasis

Lecture 12
LectureL-12

A probiotic treatment for kidney stone disease
July 22 (Fri)

9:00-9:30

Room 1（2F International Conference Room）

Cancelled－ 32 －

ISU2016

L-13

Future prospects for herbal remedies in the managementof urolithiasis
July 22 (Fri)9:30-10:00

Room 1（2F International Conference Room）

Chair
Anthony Cf. Ng
The Chinese University of Hong Kong, Hong Kong
Dr Anthony NG graduated in the Chinese university of Hong Kong in 1993 and became
an urologist in 2001. He then spent 1 year in Scotland, worked under Mr David Tolley,
and gained extensive experience in stone management.
After completion of his training, Dr Ng decided to join the Chinese University of Hong Kong in 2006 and iscurrently Director and Professor of the S.H. Ho Urology Centre, CUHK. He has a wide range of interest, inparticular in urolithiasis and prostate diseases. He was also honored with the Outstanding Young Urologist
Award in 2010 by the Asian Congress of Urology, the International Guest Scholar 2012 of the American
College of Surgeons and the World Chinese Urology Association Award 2014, as recognitions to his work in
the field.

Speaker
Mayur Danny I Gohel
Tung Wah College, Hong Kong
Danny Gohel completed his Clinical Chemistry degree in USA and returned to Hong Kong
for PhD studies under the Prof. Daisy Shum and Prof. Tom Boyde at The University ofHong Kong. He is currently the Professor and Dean of the School of Medical and Health
Sciences at Tung Wah College.
Research interests: Physico-chemical aspects of calcium oxalate crystallization, native urinary
glycosaminoglycans and Herbal medicines in Urolithiasis and diagnostics of silent stones.
Highlight of Prof. Gohel research career, is the incidence of melamine stones in children which relied on
applying all the knowledge gained, studied and seeking expert opinions, which have never been studied,radiologically examined or its metabolism known. He worked with a local Urologist, to investigate into thephysico-chemical aspects of the melamine stones and renal cell responses.

－ 33 －

LectureLecture 13

13th International Symposium on Urolithiasis

Guideline 1
G-01

The 2016 EAU Guideline on Urolithiasis
July 20 (Wed)10:00-10:30

Room 1（2F International Conference Room）

Guideline

Chair
Christian Tuerk
Department of Urology at Rudolfstiftung Clinic, Kidneystone Center (with SWL) , Austria
Christian Tuerk (*1951,Vienna, Austria), attended high school (1969 "summa cum
laude") and Medical University in Vienna (02/1975). Since then he has been working
at the Rudolfstifung Hospital, a teaching hospital of the Vienna Hospital Association,
associated with the Medical University of Vienna. After residency he became responsible assistant medical
director of it’s Kidney Stone Centre in 1986.
He served as „Visiting Professor“, among others, at Texas Southwestern Medical School and Mayo Clinic
Rochester. He published several listed and not listed publications and chapters in text books and is memberof numerous national and international urologic associations. He chairs the Austrian working groupon Urolithiasis and the working group on Guidelines on Urolithiasis of EAU. He serves as teacher at theAustrian and the European School of Urology.

Speaker
Thomas Knoll
Klinikum Sindelfingen-Böblingen gGmbH, Germany
Dr. Thomas Knoll is Associate Professor of Urology at Mannheim University Hospital,
Germany, and Head of the Department of Urology, Sindelfingen Medical Center,
University of Tuebingen, Germany. Dr. Knolls field of expertise includes endourologic,
laparoscopic and robotic surgery for urolithiasis, benign prostatic hyperplasia and uro-oncology.
Dr. Knoll won a total of 8 awards pertaining to his innovation and research, including the Arthur-SmithAward of the Endourology Society. Dr. Knoll has published over 100 manuscripts in peer-reviewed literatureand 16 book chapters. Dr. Knolls serves an Editorial board member of several journals. He is board memberof the EAU Guidelines Office, the Sections for Urolithiasis, Uro-Technology and Ethics in Live Surgery. In
2015 he was appointed as Member of the EAU Scientific Committee.

－ 34 －

ISU2016

Guideline 2
G-02

AUA Surgical Stone Management Guidelines
July 20 (Wed)

10:30-11:00

Guideline

Room 1（2F International Conference Room）

Chair
Hans-Göran Tiselius
Karolinska Institutet, Sweden
Born in Stockholm 1945. Medical education at Karolinska Institutet and University of
Lund. MD 1972. PhD in clinical chemistry 1974. Certificates of speciality in generalsurgery 1977 and urology 1979. Professor of urology at Linköping University between
1992 and 1999 and at Karolinska Institutet 1999-2010. Currently professor emeritus at Karolinska
Institutet.
Started ESWL in Sweden 1985. Responsible for ESWL in Linköping and Stockholm during more than 25
years. Main research profile: aspects on low-invasive stone removal, mechanisms of calcium stone formationand its prevention.
Co-chairman of the AUA/EAU collaboration on guidelines for ureteral stone treatment(2003-2008).
Associate Editor of Urolithiasis, Advisory Board member of Scandianvian Journal of Urology, Turkish
Journal of Urology and Urologia Internationalis.
Honorary member of EAU, eulis and the Swedish Association of Urology.

Speaker
Bodo E. Knudsen
The Ohio State University Wexner Medical Center, USA
Bodo Knudsen is the Director of the Comprehensive Kidney Stone Program at the Ohio
State University Wexner Center. He holds the rank of Associate Professor with Tenureand has served as the Department of Urology Interim Chair from September 2014
through June 2016. Dr. Knudsen completed his medical school at the University of Manitoba in 1997
and his residency in 2002. He completed his fellowship in Endourology with Drs. John Denstedt at the
University of Western Ontario in 2004. He joined the Ohio State University in 2005. Dr. Knudsen is the
Past President of the Ohio Urological Society, the Vice-President of the Engineering and Urology Society,and members of the R.O.C.K. Society and the EDGE Research Consortium. He has published over 60 peer
reviewed articles, manuscripts and book chapters.
－ 35 －

13th International Symposium on Urolithiasis

Symposium 1
S-01

Radiographic diagnosis and treatment of urolithiasis
July 19 (Tue)11:00-12:00

Room 1（2F International Conference Room）

Coordinator/Chair
Isao Hara
Department of Urology, Wakayama Medical University, Japan

Symposium

Education:
1979-1985 School of Medicine, Kobe University
1985-1986 Residence at Department of Urology Kobe University Hospital
1986-1990 Postgraduate Course, Department of Urology Kobe University School of Medicine
Research and professional experience:
1991-1993 Postdoctoral Fellow at Memorial Sloan Kettering Cancer Center
1994-2002 Instructor at Department of Urology Kobe University, School of Medicine
2002-2004 Assistant Professor at Division of Urology Kobe University School of Medicine
2004-2007 Associate Professor at Division of Urology Kobe University School of Medicine
2007-present Professor at Department of Urology Wakayama Medical University
Membership of learned societies:
The Japanese Urological Association (Boarding Member)
American Urological Association
Europaen Urological Association
Japanese Society of Endourology and ESWL (Boarding Member)
Japanese Association for Cancer Research
Japan Society for Clinical Oncology
Society for Fundamental Cancer Immunology
Japanese Society of Endourology

Coordinator/Chair
Noor Buchholz
U-merge London and SVMC Dubai, UAE
He was trained in Germany, Switzerland, Australia and Consultant Urologist in Pakistan,
Netherlands, United Kingdom, and now Dubai.
He is a leading expert in minimally invasive urological surgery, stone treatment andpermanent metal stenting of the urinary tract.
He was one of only 46 trainers worldwide recognised by the International Endourology Society (IES), andthe first such recognised trainer in Europe by the European Board of Urology (EBU). He was awarded
multiple grants and awards, is author on more than 300 original articles, is reviewer and editor for many
journals, and member of many learned societies.
He sits on the board of eULIS-EAU and the Societe Internationale d'Urologie (SIU).
He founded U-merge (Urology in emerging countries) dedicated to urological education and training.
－ 36 －

ISU2016

S-01-1 Imaging before stone surgery
Anthony Cf. Ng
SH Ho Urology Centre, The Chinese University of Hong Kong, Hong Kong

After completion of his training, Dr Ng decided to join the Chinese University of Hong Kong in 2006 and iscurrently Director and Professor of the S.H. Ho Urology Centre, CUHK. He has a wide range of interest, inparticular in urolithiasis and prostate diseases. He was also honored with the Outstanding Young Urologist
Award in 2010 by the Asian Congress of Urology, the International Guest Scholar 2012 of the American
College of Surgeons and the World Chinese Urology Association Award 2014, as recognitions to his work in
the field.

S-01-2 Imaging after stone surgery what why when
M Hammad Ather
Aga Khan University, Pakistan
Dr. Hammad Ather is a consultant urologist, Professor and head of urology at the Aga
Khan University. He is an editorial board member of many international urologicaljournals, author of over 90 articles in international peer journals and 10 book chapters.
He is also an adviser and reviewer for over 2-dozen international journals. Dr Ather was trained in Karachi
and London and has many fellowship attachments in Europe at Erasmus University, Rotterdam, Katholique
Universiteit Leuven and University College London. He has served as the General secretary of Pakistan
Association of Urological surgeons (PAUS). He is international advisory board member of eulis (EAU) since2011 and national representative of APSUO (UAA). He has special interest in urolithiasis, bladder andadvanced prostate cancer, which is his major research interest as well.

S-01-3 CT attenuation value of renal papilla: a novel predictor forstone recurrence

Yasuo Kohjimoto
Wakayama Medical University, Japan
1985-1991
M.D., Wakayama Medical University, Japan
1991-1993
Resident in Urology, Wakayama Medical University Hospital, Japan
1993-1997
Ph.D., Wakayama Medical University Graduate School of Medicine, Japan
1998-1999
Postdoctoral Fellow in Physiology, University of Massachusetts Medical School
1999-2001
Physician-in-Chief, Division of Urology, Kishiwada City Hospital, Japan,
2001-2004
Instructor of Urology, Wakayama Medical University, Japan
2004-2010
Assistant Professor of Urology, Wakayama Medical University, Japan
2010-pressent Associate Professor of Urology, Wakayama Medical University, Japan－ 37 －

Symposium

Dr Anthony NG graduated in the Chinese university of Hong Kong in 1993 and became
an urologist in 2001. He then spent 1 year in Scotland, worked under Mr David Tolley,
and gained extensive experience in stone management.

13th International Symposium on Urolithiasis

Symposium 2
S-02

Dietary habit and risk of urolithiasis
July 19 (Tue)

15:10-16:10

Room 1（2F International Conference Room）

Coordinator/ChairDavid S. Goldfarb
NYU School of Medicine, NYU Langone Medical Center, USA

Symposium

Dr. Goldfarb is Professor of Medicine & Physiology at NYU School of Medicine, Clinical
Chief of Nephrology at NYU Langone Medical Center, and Chief of Nephrology at the
New York Harbor VA Medical Center. He trained in internal medicine and nephrology
at the New York VA and NYU Langone Medical Center. He directs kidney stone prevention clinics at NYU
and the New York VA. He is the principal investigator of the cystinuria component of the Rare Kidney Stone
Consortium, funded by the NIDDK.

－ 38 －

ISU2016

S-02-1 Use of urine chemistries to assess dietary habits
John R. Asplin

Dr John Asplin attended Emory University Medical School and did his Internal Medicine
Residency at University of Cincinnati. After 3 years in the US Navy, he completed
his nephrology fellowship at University of Chicago. He did his research and clinicaltraining in the field of nephrolithiasis under the guidance of his mentor, Dr Fredric Coe. After finishing his
fellowship, Dr Asplin joined the faculty at University of Chicago. In 1995, Dr Coe and Asplin helped foundLitholink Corporation, a clinical laboratory focused on the care of kidney stone patients. Currently, Dr
Asplin holds the positions of medical director of Litholink and clinical associate at University of Chicago.
His research interests include cystinuria, metabolic evaluation of patient with urolithiasis, inhibitors of
crystallization, and new therapeutics for kidney stone patients.

S-02-2 Evidence-based dietary recommendations for stone
formers

Roswitha Siener
University Stone Centre, Department of Urology, University of Bonn, Germany
Prof. Dr. Roswitha Siener is a Professor in the Department of Urology at the Universityof Bonn, Germany, and Head of the University Stone Centre. Areas of her research arenearly all aspects of urinary stone disease, including epidemiology, pathophysiology, metabolism andnutrition.
Prof. Siener has authored numerous peer-reviewed articles, book chapters and conference abstracts. She
has received several scientific awards both nationally and internationally. Prof. Siener is Editorial board
member of the Journal of Translational Medicine, Urolithiasis and Uro-News and board member of theEuropean Association of Urology (EAU) section of urolithiasis (EULIS).

S-02-3 Prospects for dietary therapy of urolithiasis
David S. Goldfarb
NYU Langone Medical Center, USA－ 39 －

Symposium

Litholink Corporation, USA/University of Chicago, USA13th International Symposium on Urolithiasis

Symposium 3
S-03

Uric acid
July 19 (Tue)

16:10-17:10

Room 1（2F International Conference Room）

Coordinator/Chair
Alberto Trinchieri
Urology Unit, Manzoni Hospital, Lecco, Italy

SymposiumPERSONAL DETAILS
Biella, Italy, 8 April 1953
ACADEMIC QUALIFICATIONS
Fellow of the European Board of Urology (FEBU) (1992)
Specialization of Medical Nephrology (1986) and Urology (1981)
M.D.(1978)
Lecturer, Urology School, University of Milan (1985 - 2004)
PROFESSIONAL EXPERIENCE
2003-present: Director of the Urology Unit, Dpt Surgery, A.Manzoni Hospital, Lecco
1986-2002 : Assistant Urologic Clinic of University of Milan, IRCCS Ospedale Maggiore di Milano
SOCIETIES AND CONGRESSESMember of the Italian Society of Urology (1981-present) and of the European Society of Urology(1986-present)
Member of the Board of the Section of Urology of the European Association of Urology (eULIS)(2009-present) and of the Board of the International Society of Urolithiasis (2008-present)
Co-Chairmen and Chairman of the Congress of the European Society of Urolithiasis (Parma 1999 andCernobbio 2009)

Coordinator/Chair
Khashayar Sakhaee
Department of Internal Medicine, Division of Mineral Metabolism, Charles and Jane Pak
Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern
Medical Center, Dallas, USA
Dr. Sakhaee, Laura Kim Pak, Professor in Mineral Metabolism Research and Osteoporosis
at the UT Southwestern Medical Center, Dallas TX, USA. He is Chief of Division of Mineral Metabolism.
Dr. Sakhaee received his M.D. in Iran and Residency and Nephrology Fellowship at University Hospital of
Cleveland, Ohio and UT Health Science Center at Dallas, TX, USA. He joined the faculty at UT Southwestern
Medical School in 1982 and promoted to Professor in 1993. Dr. Sakhaee research interests are related
to clinical investigations underlying pathophysiological mechanisms of kidney stone formation. His
publications, which number over 160, speak to active original investigative initiatives, as well as his demandas an author of many references in the field of Urolithiasis.
－ 40 －

ISU2016

S-03-1 Epidemiology of uric acid nephrolithiasis
Alberto Trinchieri
Urology Unit Manzoni Hospital Lecco, Italy

S-03-2 Recent advances in pathophysiology of uric acid
Khashayar Sakhaee
University of Texas Southwestern Medical Center, USA

S-03-3 Uric acid urolithiasis as a feature of the metabolic
syndrome: a multi-hit model

Orson Moe
UT Southwestern Medical Center, USA
Orson Moe received his medical degree from the University of Toronto and is Professorof Internal Medicine and Physiology, Director of the Pak Center of Mineral Metabolism
and Clinical Research, and Chief of the Nephrology Division at the University of Texas Southwestern Medical
Center, USA. Moe holds the Charles and Jane Pak Distinguished Chair in Mineral Metabolism Research andthe Donald Seldin Professorship in Clinical Investigation. Moe conducts both basic science and patientoriented research on renal physiology and metabolism, and epithelial biology. He is the editor of Current
Opinion in Nephrology and Hypertension, and the textbook Seldin and Giebiesch’s The Kidney: Physiology
and Pathophysiology. He is currently a member of the American Society of Clinical Research, American
Association of Physicians, American Society of Nephrology, and American Physiologic Society.

－ 41 －

Symposium

nephrolithiasis (UA)

13th International Symposium on Urolithiasis

Symposium 4
S-04

Ureteroscopy (URS)
July 20 (Wed)

11:10-12:10

Room 1（2F International Conference Room）

Coordinator/Chair
Kemal Sarica
Department of Urology, Dr. Lutfi KIRDAR Research and Training Hospital, Turkey

Symposium

Graduated Faculty & Year: University of Ankara, Medical School, 1981
Place & Date of Professorship: University of Gaziantep, Medical School,
Dept. of Urology, 2003
Professional Publications (215)
Number of Books/Book Chapters: 9
Memberships in Associations• American Urological Association (AUA)• European Urological Association (EAU)• Endourological Society• Eurolithiasis Society (EULIS)International positions in Associations• Chairman : EAU Section of Eurolithiasis (EULIS)• Member, Urolithiasis Guidelines Committee (EAU)• Member , International Urolithiasis Society board (IUS)• Co-chairman International Alliance of Urolithiasis (IAU)
Member ( Editorial board, International journals )Urological Research (Member, editorial board)Archiv.Italian.Urol.Androl (Member, editorial board)

Coordinator
Takashi Arakawa
International University of Health and Welfare Mita Hospital, Japan
1979 Graduated from Kitasato University School of Medicine .
1988 to 2002 Chief, Division of Urology, Urolithiasis Lithotripsy Center of Sagamidai
Hospital.
2005 Associated Professor, Kitasato University Hospital .
2006 Professor , International University of Welfare & Health Mita Hospital.

－ 42 －

ISU2016

Chair
Petrisor Geavlete

Academician (Corresponding Member) – Romanian Academy of Medical Sciences
Professor of Urology, MD, PhD (“magna cum laude”), first degree Romanian specialist
in Urology, Chief of Clinical Department, “Saint John” Emergency Clinical Hospital,
Bucharest, Romania, Vice-President of the Romanian Association of Urology. Member/Board member
in 15 International Urological Societies: Full Member – European Association of Urology; EAU Officer(Clinical Research Office 2002-2004); Board member – EAU Video Committee (2005-2013), Board
member – European Society of Imaging in Urology (ESUI); Full Member – Société Internationale d’Urologie– Romanian representative (Deputy Delegate); Correspondent Membership – American Association of
Urology; International Member – British Association of Urological Surgeons; Membre étranger – Association
Française d’Urologie; Full Member – Endourological Society; Associate Member – EAU Section of Urolithiasis(EULIS); Board of Directory Member – Société Internationale d’Urologie (2015-2016).
Member in the Board of Doctorate School (PhD leadership former) – “Carol Davila” University of Medicine,
Bucharest.
Author or co-author in over 1,100 papers published in journals, national and international congresses or
meetings, abstract books of the most important urological publications and congresses in the world.
Over presented 300 videos (first author or co-author) and published 22 books (author, co-author or Editor).
Faculty in over 250 meetings during International Congresses.
Reviewer for the most international publications and urological meetings.
35 national and international distinctions.
Granted with “Health High Order” (“Commander” grade) offered by Romanian President in 2004.

－ 43 －

Symposium

Saint John Emergency Clinical Hospital, Romania

13th International Symposium on Urolithiasis

S-04-1 Management of ureteral stones with semirigid

ureteroscopy: tips and tricks for a successful andcomplication free procedure

Sven Lahme
Center for minimally-invasive Therapy - robotic-assisted Surgery
Siloah St. Trudpert Hospital Pforzheim, Germany

Symposium

Professor Sven Lahme, MD, is Head of Department of Urology, Siloah St. Trudpert Hospital, Pforzheim,
Germany since 2004. His scientific education was done at the Department of Urology, University Hospitalof Tübingen, Germany from 1993 to 2004. His main field is minimally invasive therapy, particularly
endourology. In 2001 he introduced the Mini-PCNL technique in adults and presented the first speciallydesigned nephroscope for Mini-PCNL. Today the Mini-PCNL technique is the treatment of choice inpercutaneous stone removal. He is also strongly involved in flexible ureterorenoscopy and the developmentof new disposables in endourology. A few years ago the smallest tipless basket on the market (1.2F) had
been introduced. Mini PCNL as well as flexible URS are frequently presented by live surgery at national andinternational meetings.

S-04-2 Management of renal stones with flexible ureteroscopy :tips and tricks for a successful and complication free
procedure

Petrisor Geavlete
Saint John Emergency Clinical Hospital, Romania

S-04-3 Robotic assisted flexible ureterorenoscopic (Robotic fURS)
management of renal calculi

Kemal Sarica
Department of Urology, Dr. Lutfi KIRDAR Research and Training Hospital, Turkey－ 44 －

Symposium

ISU2016－ 45 －

13th International Symposium on Urolithiasis

Symposium 5
S-05

Percutaneous nephrolithotomy (PNL)
July 20 (Wed)

15:20-16:20

Room 1（2F International Conference Room）

Coordinator/Chair
Madhu S. Agrawal
Global Rainbow Healthcare, India

Symposium

QUALIFICATIONS:• MBBS 1979. University topper with Honors and Gold Medals, 'Best Student'.
• MS (Surgery) 1983, MCh (Urology) 1989.
• Obtained premature retirement as Professor from SN Medical College, Agra 2009.
• Presently Head, Department of Urology, Global Rainbow Healthcare, Agra, India.
HIGHLIGHTS:• >100 publications in National & International Journals, text book chapters.
• >200 guest lectures, >200 papers presented in National & International conferences with many Best
Paper awards.
• Reviewer for National & International Journals, including: BJUI, J Endourology, Urology, IJU, IJMR.
• One of the pioneers in Endourology in India, conducted >80 live workshops at National and International
level.
• Received ‘Rao Oration’ 2006-07, ‘Kataria Oration’ 2010-11, & ‘Marudhara Oration’ 2013-14.
• Received President’s Gold Medal 2015-16 of Urological Society of India.

－ 46 －

ISU2016

S-05-1 How to get the right access in PCNL and Endoscopic
combined intrarenal surgery

Junichi Matsuzaki
Ohguchi Higashi General Hospital, Japan

EXPERIENCE:
Urological Chief in Department of Urology Ohguchi Higashi General Hospital since 2002.
Deputy director in Ohguchi Higashi General Hospital since 2015.
PROFESSIONAL AFFILIATION:
A member of Japanese Urological Association since 1991.
A member of Japanese Cancer Association since 1991.
A member of Japanese Society of Clinical Oncology since 1991.
A member of Japanese Society of Endourology since 2004.
A member of American Urological Association since 2011.
A councilor of Japanese Society on urolithiasis Research since 2014
A councilor of Japanese Society of Endourology since 2014
Japanese Board Certified Instructor since 2000

S-05-2 Minimally-invasive PNL
Madhu S. Agrawal
Global Rainbow Healthcare, Agra, India

S-05-3 MIP vs flexible Ureteroscopy: what is the evidence
Madhu S. Agrawal
Global Rainbow Healthcare, Agra, India－ 47 －

Symposium

EDUCATION:
M.D., Yokohama City University Medical School, March 1989
Ph.D., Yokohama City University Medical School, March 1999

13th International Symposium on Urolithiasis

Symposium 6
S-06

Stone recurrence
July 20 (Wed)

16:20-17:20

Room 1（2F International Conference Room）

Coordinator/Chair
José M. Reis Santos
Uroclínica - Centro Clínico de Urologia, Lda., Portugal

Symposium

CURRICULUM VITAE
José Manuel Reis Santos. Born in Portugal on 28-02-46
Hospital & Academic Career• 1971 Graduation in Medicine, Lisbon University• 1976 Founding Member and clinical director of Uroclínica, Lisbon• 1979 Consultant Urologic Surgeon• 1979 - 2002 Assistant Professor Urology, Lisbon New University• 1986 Founding Member, Institute of Urology renamed in 2002, British Hospital Lisbon XXI• 1988 Head of Department of Urology HCL Lisbon• 1992 Fellow of the European Board of Urology (FEBU)• 2002 - 2014 Professor of Bio-Engineering, Portuguese Catholic University• Invited Professor, centres in EU, USA, Canada, Brazil etc.
• Author of various publications and book chapters• One of the founders and Full member of eULIS board• EAU, AUA, BAUS, APU, etc.society member• Principal investigator in 29 clinical trials ( Phase II-IV) and peer reviewer for various urologic journals－ 48 －

ISU2016

Chair
Kemal Sarica
Department of Urology, Dr. Lutfi KIRDAR Research and Training Hospital, Turkey
Graduated Faculty & Year: University of Ankara, Medical School, 1981
Place & Date of Professorship: University of Gaziantep, Medical School,
Dept. of Urology, 2003
Professional Publications (215)
Number of Books/Book Chapters: 9

SymposiumMemberships in Associations• American Urological Association (AUA)• European Urological Association (EAU)• Endourological Society• Eurolithiasis Society (EULIS)International positions in Associations• Chairman : EAU Section of Eurolithiasis (EULIS)• Member, Urolithiasis Guidelines Committee (EAU)• Member , International Urolithiasis Society board (IUS)• Co-chairman International Alliance of Urolithiasis (IAU)
Member ( Editorial board, International journals )Urological Research (Member, editorial board)Archiv.Italian.Urol.Androl (Member, editorial board)－ 49 －

13th International Symposium on Urolithiasis

S-06-1 Reasons for failure of recurrence prevention
Bernhard Hess
Internal Medicine and Nephrology, Kidney Stone Center Zurich, Klinik Im Park, Zurich,
Swizerland
1972-1978 : Medical School Zurich.
1980 : M.D. degree, Faculty of Medicine, Zurich.
1980-1981 Pathology, Liestal/Basle
1981-1989 Internal Medicine and Nephrology in Zurich and Chicago

Symposium

1989-1999: Chief-Resident and Chief ai of General Internal Medicine, University HospitalBerne
1994 Associate Professor Nephrology, University of Berne
1999-2005: Chief of Internal Medicine, Hospital Zimmerberg, Waedenswil/Zurich
2002 Associate Professor Internal Medicine, University of Zurich
7/2005- : Internal Medicine and Nephrology, Hirslanden Klinik Im Park Zurich and Paracelsus
Hospital Richterswil/Zurich, Switzerland
Founder/Chief of Kidney Stone Center Zurich
Nationally/internationally 700 lectures/workshops.
More than 150 scientific papers/reviews/book chapters.
Grant recipient for research on idiopathic calcium nephrolithiasis
Member of Editorial Board of Urolithiasis, regular reviewer for nephrology and urology journals worldwide
Honorary Member of Swiss Society of Urology, former executive member of eULIS (Eurolithiasis Society,part of EAU)

－ 50 －

ISU2016

S-06-2 How to prevent renal stone disease recurrence: a review
from my practice

Wen ZhongDepartmet of Urology, The First Affiliated Hospital of Guangzhou Medical University,
Guangzhou, China

S-06-3 Can endoscopic study of the papilla with new tools help
fight recurrence?

James C. Williams
Indiana University School of Medicine, USA
James Williams is Professor of Anatomy and Cell Biology at the Indiana University Schoolof Medicine in Indianapolis, USA, and Adjunct Professor of Urology, University of Southern
Denmark, in Odense. His primary area of research is in understanding urinary stone diseases. Recent studies
have revealed that some calcium oxalate stone formers produce stones solely on Randall's plaque (interstitial,
white plaque), while others also produce plugging of collecting ducts in the renal papilla. Visualization ofthese distinct mechanisms (interstitial plaque formation versus ductal plugging) has required study of thestructure of the tiny stones that were found growing on the renal papillae in patients. This characterization ofthese stones has been possible only because of the development of micro-computed tomographic (micro CT)
imaging of stones, work begun in Prof. Williams' laboratory.

－ 51 －

Symposium

As an associate professor in the Guangzhou Medical University, youth committee
of International Alliance of Urolithiasis (IAU). Major in Endourology, and skilled in urinary tract stone
management, such as percutaneous nephrolithotomy, flexible/rigid ureteroscopy, especially good at Chinesemini-PCNL and super mini-PCNL.

13th International Symposium on Urolithiasis

Symposium 7
S-07

OxalateJuly 21 (Thu)

10:10-11:10

Room 1（2F International Conference Room）

Coordinator/Chair
Ross Holmes
University of Alabama at Birmingham, USA

Symposium

Ross Holmes is a Professor in the Department of Urology at the University of Alabama
at Birmingham. He has studied kidney stone disease for over 25 years with a focus on
the contributions of dietary oxalate and the endogenous synthesis of oxalate to urinary
oxalate excretion. An active area of research is identifying strategies that will reduce these contributions.
Approaches include dietary modifications and siRNA therapies to decrease hepatic oxalate production.

Coordinator/Chair
Dawn S. Milliner
Mayo Clinic, Division of Nephrology, Mayo Clinic Hyperoxaluria Center, Rare Kidney Stone
Consortium, USA
Dawn Milliner, M.D. received internal medicine and nephrology training at Mayo Clinic
and pediatric nephrology at Children's Hospital of Los Angeles. She is a member ofthe Division of Nephrology, Department of Internal Medicine, and the Division of Pediatric Nephrology,
Department of Pediatrics at the Mayo Clinic College of Medicine.
Dr. Milliner conducts research in pediatric stone disease, oxalate, and inherited forms of nephrolithiasis.
She chaired the Seventh International Workshop on Primary Hyperoxaluria, served as chair of the Scientific
Advisory Board of the Oxalosis and Hyperoxaluria Foundation and is past president of the Research
on Calculus Kinetics Society. Dr. Milliner is medical director for the Mayo Clinic Hyperoxaluria Center,established by the Oxalosis and Hyperoxaluria Foundation and is principal investigator for the Rare Kidney
Stone Consortium, funded by the NIH.

－ 52 －

ISU2016

S-07-1 Endogenous and dietary sources of oxalate
Ross P. Holmes
University of Alabama at Birmingham, USA

S-07-2 Stone disease: idiopathic and secondary hyperoxaluria
University Stone Centre, Department of Urology, University of Bonn, Germany
Prof. Dr. Roswitha Siener is a Professor in the Department of Urology at the Universityof Bonn, Germany, and Head of the University Stone Centre. Areas of her research arenearly all aspects of urinary stone disease, including epidemiology, pathophysiology,
metabolism and nutrition.
Prof. Siener has authored numerous peer-reviewed articles, book chapters and conference abstracts. She
has received several scientific awards both nationally and internationally. Prof. Siener is Editorial board
member of the Journal of Translational Medicine, Urolithiasis and Uro-News and board member of theEuropean Association of Urology (EAU) section of urolithiasis (EULIS).

S-07-3 Kidney disease: primary and enteric hyperoxaluria
Dawn S. Milliner
Mayo Clinic, Division of Nephrology, Mayo Clinic Hyperoxaluria Center, Rare Kidney Stone
Consortium, USA－ 53 －

Symposium

Roswitha Siener

13th International Symposium on Urolithiasis

Symposium 8
S-08

Inflammation and formation of kidney stone
July 21 (Thu)

11:10-12:10

Room 1（2F International Conference Room）

Coordinator/Chair
Saeed R. Khan
Department of Pathology, Department of Urology, College of Medicine, University of
Florida, USA

Symposium

Saeed R Khan is Finlayson Professor of Urological Research in the Department ofUrology, University of Florida and Director of their Training Program in Benign Urology
Research. He is Associate Editor of Urolithiasis. Dr. Khan investigates all aspects of stone disease using
experimental models as well as clinical specimens. His research has been supported by US National
Institutes of Health. He has mentored over thirty graduate students and twenty post-doctoral fellows,
authored more than four hundred publications including refereed articles in peer reviewed journals, bookchapters, editorials, review articles and numerous abstracts. He has also edited a book, Oxalate in Biological
Systems as well as Proceedings of the International Symposia. He has participated in numerous national
and international meetings, giving more than seventy invited lectures and keynote addresses.

Coordinator/Chair
Takahiro Yasui
Department of Nephro-urology, Nagoya City University Graduate School of Medical
Sciences, Japan
Education:
M.D. in 1994, Ph.D. in 2000 from the Nagoya City University Graduate School of Medical
Sciences.
Current Position:2015 Professor, Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences
Professional memberships:
Japanese Urological Association, Japanese Society on Urolithiasis Research (Director), Japanese Societyof Endourology (Councilor), Japanese Society of Nephrology (Councilor), Japanese Society for Endoscopic
Surgery, Japanese Association of Endocrine Surgery, American Urological Association, Société Internationale
d'Urologie, etc.
Awards:Sakaguchi-Prize (Japanese Urological Association) in 2003, 1st Prize for Presentation (Japanese Society on
Urolithiasis Research) in 2007, Best Presentation (Japanese Society of Nephrology) in 2010, Medical ResearchAward (Japan Medical Association) in 2011, International Journal of Urology Reviewer of the Year in 2012, Best
Poster (European Association of Urology) in 2014, Best Poster (American Urological Association) in 2015 etc.
－ 54 －

ISU2016

S-08-1 Gene expression signature of human renal epithelial cells
involved in oxalate-induced inflammation

Hari K. Koul

Dr. Hari K. Koul is the Carroll W. Feist Endowed Chair and Professor and Chairman of the Departmentof Biochemistry and Molecular Biology, LSUHSC, Shreveport, LA-USA. Dr. Koul is recognized as a basictranslational researcher in Urologic diseases. Of pertinent interest to Urolithiasis, Dr. Koul pioneered the fieldof oxalate nephrotoxicity and these studies have been funded by NIH since 1996 with a focus on evaluating
the molecular signaling pathways associated with oxalate nephrotoxicity. Dr. Koul provided the first direct
demonstration of toxic effects of oxalate to the renal epithelial cells, which led to a paradigm shift in our
thinking as oxalate was considered as an inert metabolic end product. Over the years’ major focus of Dr. Koul’s
research has been understanding the molecular mechanisms of oxalate renal cell interactions.

S-08-2 Intrarenal inflammation and presence of inflammatory

proteins in urine and stone matrix of urolithiasis patients:
do these evidences give us a clue of how inflammation
mediates the formation of urinary stones?

Chanchai Boonla
Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok,
ThailandI graduated B.Sc. in Medical Technology in 1999 and Ph.D. in Medical Biochemistry in 2004 from Khon Kaen
University, Thailand. During my doctoral study, I trained research abroad at School of Biological Science,
University of Manchester, UK in 2002, and at Department of Biochemistry and Biophysics, University of North
Carolina at Chapel Hill, USA in 2003. I did my postdoctoral research (Humboldt Fellowship) at University ofFreiburg, Germany in 2008. Now I am working as Assistant Professor at Department of Biochemistry, Facultyof Medicine, Chulalongkorn University, Bangkok Thailand. My research is focusing on urolithaisis and bladdercancer, especially in the aspects of how oxidative stress or reactive oxygen species (ROS) modifies epigenetic
patterns during the pathogenesis and progression of urolithaisis and bladder cancer.

－ 55 －

Symposium

Department of Biochemistry and Molecular Biology, LSU Health Sciences Center
Shreveport, LA and Shreveport, USA/Overton Brooks Veterans Administrative Medical
Center, Shreveport, LA and Shreveport, USA/Feist Weiller Cancer Center, LSU Health
Sciences Center Shreveport, LA and Shreveport, USA13th International Symposium on Urolithiasis

S-08-3 Macrophage-derived cytokines and chemokines may be
new markers for calcium oxalate stone formation risk inhumansAtsushi Okada
Department of Nephro-urology, Nagoya City University Graduate School of Medical
Sciences, Japan

Symposium

Atsushi Okada, MD, PhD is Associate Professor of Department of Nephro-urology, Nagoya City University
Graduate School of Medical Sciences, Nagoya, Japan. He graduated from Nagoya City University, Medical
School (Nagoya, Japan) in 1998 and Graduate School of Medical Sciences, Nagoya City University (Nagoya,Japan) in 2008. He works at the university hospital and educates the next generation as a proctor of robotassisted operation, laparoscopic surgery, ESWL, URS and PNL. In 2000, He started a research on kidneystone formation using experimental animals and developed the first experimental kidney stone model
mice. And, he determined suppressive roles of anti-inflammatory macrophages for kidney stone formation
by crystal phagocytosis and processing. His current interests focus on the risk diagnosis and moleculartargeted therapy for kidney stones based on the mechanisms of stone formation.

－ 56 －

Symposium

ISU2016－ 57 －

13th International Symposium on Urolithiasis

Symposium 9
S-09

Growth-inhibition of urolithiasis
July 21 (Thu)

13:30-14:30

Room 1（2F International Conference Room）

Coordinator/Chair
Neil S. Mandel
Medical College of Wisconsin, Zablocki VA Medical Center, USA

Symposium

I obtained my PhD in Chemistry in 1971 from the University of Pennsylvania, was a
postdoctoral fellow in x-ray crystallography from 1972-1974 at the California Instituteof Technology and was a Research faculty member at Caltech from 1974-1977. I was
appointed an Assistant Professor of Medicine and Orthopedic Surgery at the Medical College of Wisconsinin 1978 and was appointed Professor of Medicine, Biophysics, and Biochemistry a few years later. I
initiated and chaired the Biophysics Graduate Program at MCW for many years. I was appointed the
Associate Chief of Staff for Research at the affiliated VA Medical Center as well as the Associate Dean for
Research for 24 years. My interest in urolithiasis started upon my arrival at MCW and has continued now
for more than 35 years.

Coordinator/Chair
Jeffrey A. Wesson
Department of Veterans Affairs, USA/Medical College of Wisconsin, USA
Jeffrey A. Wesson was born in 1954 in Rockford, Illinois, USA. He received his PhD
in polymer physical chemistry from the University of Wisconsin-Madison in 1983,
and he worked as a chemist at the Eastman Kodak Company Research Laboratories in
Rochester, New York for 9 years on various problems in polymer characterization, particularly gelation
behavior, before starting his career in medicine. He received his MD from the Medical College of Wisconsin,
Milwaukee, Wisconsin in 1994. Following Internal Medicine residency and Nephrology fellowship there,
he joined the faculty at the Medical College of Wisconsin in 1999, where he is now a full professor. His
medical research career began during residency and has focused on the influence of urinary proteins andpolymers on calcium oxalate crystallization and stone formation.

－ 58 －

ISU2016

S-09-1 The inhibitor/promoter paradox in kidney stone disease:
contributions of proteins and other macromolecules tocalcium oxalate crystallization

Jeffrey A. Wesson
Department of Veterans Affairs, USA/Medical College of Wisconsin, USA

S-09-2 The role of osteopontin in stone formation
Department of Nephro-urology, Nagoya City University Graduate School of Medical
Sciences, Japan
Education:
M.D. in 1994, Ph.D. in 2000 from the Nagoya City University Graduate School of Medical
Sciences.
Current Position:2015 Professor, Department of Nephro-urology, Nagoya City University Graduate School of Medical
Sciences
Professional memberships:
Japanese Urological Association, Japanese Society on Urolithiasis Research (Director), Japanese Societyof Endourology (Councilor), Japanese Society of Nephrology (Councilor), Japanese Society for Endoscopic
Surgery, Japanese Association of Endocrine Surgery, American Urological Association, Société Internationale
d'Urologie, etc.
Awards:Sakaguchi-Prize (Japanese Urological Association) in 2003, 1st Prize for Presentation (Japanese Society
on Urolithiasis Research) in 2007, Best Presentation (Japanese Society of Nephrology) in 2010, Medical
Research Award (Japan Medical Association) in 2011, International Journal of Urology Reviewer of theYear in 2012, Best Poster (European Association of Urology) in 2014, Best Poster (American Urological
Association) in 2015 etc.

－ 59 －

Symposium

Takahiro Yasui13th International Symposium on Urolithiasis

S-09-3 Inhibitors of urinary crystallisation processes: what are
they and are they clinically important in urolithiasis?

Allen L. Rodgers
University of Cape Town, South Africa

Symposium

Allen Rodgers MSc, PhD is currently Emeritus Professor & Senior Research Scholar at
the University of Cape Town, South Africa, a position which he has held since January
2012. Prior to this he was Professor and Head of the Department of Chemistry for 11 years. He is a Lifetime Fellow of the University of Cape Town and a Fellow of the Royal Society of South Africa. His research
focus for the past 35 years has been the physicochemical aspects of calcium kidney-stone disease, a field inwhich he has published over 150 articles in peer-reviewed papers, conference proceedings and abstracts.
He has trained 15 PhD and 12 MSc students. He is an Associate Editor of Urolithiasis and has served on theadvisory boards of many international conferences on Urolithiasis.

－ 60 －

Symposium

ISU2016－ 61 －

13th International Symposium on Urolithiasis

Symposium 10
S-10

Life style-related risk and quality of life in stone formers
July 21 (Thu)

15:40-16:40

Room 1（2F International Conference Room）

Coordinator/Chair
Giovanni Gambaro
Fondazione Policlinico A. Gemelli, Catholic University, Rome, Italy

Symposium

GAMBARO GIOVANNI, MD, PhD.
Graduated in Padova, Italy, cum laude.
Specialist in Internal Medicine and Nephrology
PhD in Experimental Medicine/Nephrourological sciences
Past professional experience: Germany, UK.
Formerly Consultant, Academic Hospital, Padova; Associate Professor, Nephrology, Academic Hospital,
Verona, Italy.
Full Professor of Nephrology, Academic Hospital, Catholic University, Roma, Italy
Director of Division of Nephrology; Policlinico A. Gemelli Academic Hospital, Roma, Italy
Director of the Postgraduate School of Nephrology, Catholic University, Roma, Italy.
Author of more than 300 papers published in international journals among which New Engl J Med, Lancet,
JAMA, Eur Urol, JASN, KI, Nature Genetics, Nature.
H-index 31
Member of the scientific board of the EULIS and delegate in the board of ERA EDTA
Editor in chief of the Journal of Nephrology (official journal of the Italian Society of Nephrology)－ 62 －

ISU2016

S-10-1 Life style-related risk and quality of life in stone formers
Cancelled

S-10-2 Chronic renal pain in medullary sponge kidney (MSK)
Giovanni Gambaro

S-10-3 Lifestyle factors and risk of urolithiasis
Pietro Manuel Ferraro
Division of Nephrology, Fondazione Policlinico A. Gemelli, Catholic University, Italy
Dr. Ferraro received his M.D. at the Catholic University of the Sacred Heart in Rome,and specialized in Nephrology at the Tor Vergata University. He pursued a M.Sc. in
Epidemiology at the Harvard School of Public Health in Boston, and a Ph.D. in Endocrine
Sciences at the Catholic University of the Sacred Heart, where he is currently working as Teaching Assistant.

－ 63 －

Symposium

Division of Nephrology, Fondazione Policlinico A. Gemelli, Catholic University, Rome, Italy

13th International Symposium on Urolithiasis

O-06

Oral Session

Topography, composition and structure of incipient
Randall's plaque at the nanoscale level

Oral Session 1

Emmanuel Letavernier

Diagnosis and economics of urolithiasis
July 19 (Tue)Université Pierre et Marie Curie-Paris VI Sorbonne Universités,France10:00-10:48

Room 1（2F International Conference Room）

O-07
Characterization of inner medullary collecting duct
plug formation among idiopathic calcium oxalate stone
formers

Chairs: Fazil Y. Marickar(Mount Zion Medical College, India)

Takuo Koide(Daito Central Hospital, Japan)

John C. Lieske
Mayo Clinic, Rochester, USA

O-01
Symptoms and biochemical status

O-08

Fazil Y. Marickar

Papillary calcifications in uric acid stone formers (UASF):
first results

Mount Zion Medical College, India

Walter L. Strohmaier

O-02

Klinikum Coburg, Germany

Is it possible to identify urinary stones in a doctor's
office?

O-09

Paul Eapen

Oral Session

Papillary calcifications: a new prognostic factor in
idiopathic calcium oxalate urolithiasis (CaOxU)

University of Kentucky, USA

Walter L. Strohmaier

O-03
Effects of seasonal changes in ureterolithiasis morbidity
on the diagnostic relevance in emergency clinicalpractice
Hiroki Fukuhara

Klinikum Coburg, Germany

Oral Session 3
Uric acid stones and others

Nihonkai General Hospital, Japan

July 20 (Wed)O-04

9:10-9:58

Room 2（2F 201）

Economics of stone metaphylaxis in the diagnosis
related groups (DRG) calculation system in Germany

Chairs: Naim M. Maalouf(University of Texas Southwestern Medical Center, USA)

Walter L. Strohmaier

Kiyoko Kaneko

Klinikum Coburg, Germany(Faculty of Pharma Sciences, Teikyo University, Japan)

O-10

Oral Session 2

Role of serum uric acid in metabolic changes incalculogenesis

Randall’s plaques and hypercalciuria
July 19 (Tue)Fazil Y. Marickar

13:20-14:20

Mount Zion Medical College, India

Room 1（2F International Conference Room）

O-11

Chairs: John C. Lieske(Mayo Clinic, Rochester, USA)

Makoto Morozumi(Department of Urology, Saitama Medical Center, Saitama
Medical University, Japan)

Higher blood glucose is associated with higher urine
citrate excretion

O-05
Upregulation of osteogenic pathways in a rat model ofcalcium oxalate nephrolithiasis
Saeed R. Khan
Department of Pathology, Department of Urology, College ofMedicine, University of Florida, USA－ 64 －

John C. Lieske
Mayo Clinic, Rochester, USAISU2016

O-12

Oral Session 5

Association between urine calcium excretion and bonemineral density in calcium stone formers

Epidemiology and nutrition

Naim M. Maalouf

July 20 (Wed)

University of Texas Southwestern Medical Center, USA

11:10-12:10

Room 2（2F 201）

O-13

Chairs: Olivier Bonny

Patients' compliance in the prevention of uric acidurolithiasis(University of Lausanne, Switzerland/University Hospital
Lausanne, Switzerland)

Keiichi Tozawa

Walter L. Strohmaier(Department of Nephro-urology, Nagoya City University
Graduate School Medical Sciences, Japan)

Klinikum Coburg, Germany

O-19
Demography and symptoms

Oral Session 4

Fazil Y. Marickar

Pathogenesis of stones

Mount Zion Medical College, India

10:00-11:00

Room 2（2F 201）

O-20
Are there seasonal variations of renal colics in calcium
oxalate stone formers in Germany?

Chairs: Shizuka Iida
(Iida Clinic, Japan)

Walter L. Strohmaier

Emmanuel Letavernier

Klinikum Coburg, Germany(Université Pierre et Marie Curie-Paris VI Sorbonne
Universités, France)

O-21

Synergistic role of calcium and vitamin D in a murine
model of kidney stone disease

Impact of kidney stones and conventional risk factors on
the incidence of chronic kidney disease according to 2
sets of diagnostic criteria in Japanese men

Emmanuel Letavernier

Ryosuke Ando

O-14

Department of Nephro-urology, Nagoya City University Graduate
School of Medical Sciences, Japan

Université Pierre et Marie Curie-Paris VI Sorbonne Universités,FranceO-22

O-15

Comparison of food intake assessed by food dairy and
PRODI.6 analysis with 24 h urine excretion in Swiss
kidney stone formers

NLRP3 inflammasomes are activated in oxalate
nephropathy
Saeed R. Khan

Olivier Bonny

Department of Pathology, Department of Urology, College ofMedicine, University of Florida, USA

University of Lausanne, Switzerland/University Hospital Lausanne,
Switzerland

O-16

O-23

Urinary biomarkers for renal damage in primary
hyperoxaluria

Swiss Kidney Stone Cohort: a prospective cohort ofSwiss stone formers

Xiangling Wang

Olivier Bonny

Mayo Clinic, USA

University of Lausanne, Switzerland/University Hospital Lausanne,
Switzerland

O-17
Selective protein enrichment in calcium oxalate stonematrixJeffrey A. Wesson
Department of Veterans Affairs, USA/Medical College of Wisconsin,
USA

O-18
Type of stone disease and metabolic derangement
Fazil Y. Marickar
Mount Zion Medical College, India－ 65 －

Oral Session

July 20 (Wed)13th International Symposium on Urolithiasis

Oral Session 6

Oral Session 7

Medical management of urolithiasis
July 20 (Wed)

ESWL and endourology

13:30-14:30

July 20 (Wed)Room 2（2F 201）

Chairs: Satoshi Yamaguchi

14:30-15:18

Room 2（2F 201）

Chairs: Bodo E. Knudsen(Department of Urology, Kitasaito Hospital, Japan)(The Ohio State University Wexner Medical Center, USA)

Taro Iguchi

Takashi Arakawa(Department of Urology, Osaka City University Graduate
School of Medicine, Japan)(International University of Health and Welfare Mita
Hospital, Japan)

O-24

O-29

Protective role of bergenin in ameliorating
mitochondrial dysfunction associated with CaOx
induced hyperoxaluria

Ureteral stones at Funabashi Clinic: a study of 777 cases
based on stone composition
Mika Kino

Deepika Aggarwal

Funabashi Clinic, Japan

Department of Biochemistry, South Campus, Panjab University
Chandigarh, India

O-30
Computational simulation of endoscopic stone surgery:extra- and intra-three-dimensional fly through imaging
in upper urinary tract

O-25
Medical management of calcium phosphate stone
formers- impact of potassium citrate vs citric acid

Yasushi Yoshino

Oral Session

Naim M. Maalouf

Department of Urology, Nagoya University Graduate School of
Medicine, Japan

University of Texas Southwestern Medical Center, USA

O-26

O-31

Renal stone clinic: how well do patients perceive
physician's explanations and recommendations ?

Investigation of the ideal position for percutaneous
nephrolithotomy: prone position vs. modified Valdivia
position

Bernhard Hess

Shuzo Hamamoto

Internal Medicine and Nephrology, Kidney Stone Center Zurich,
Klinik Im Park, Zurich, Switzerland

Nagoya City University Graduate School of Medical Sciences,
Japan/SMART Study group, Japan

O-27
The change of renal function after treatment with shock
wave lithotripsy for urolithiasis; long-term follow-up
Taro Iguchi
Department of Urology, Osaka City University Graduate School of
Medicine, Japan

O-32
Dusting vs basketing during ureteroscopic lithotripsy:
what is more efficacious? A multi-center prospective
trial from the EDGE research consortium
Bodo E. Knudsen
The Ohio State University Wexner Medical Center, USA

O-28
Role of alpha adrenergic blockers in uretric stones
Fazil Y. Marickar
Mount Zion Medical College, India－ 66 －

ISU2016

O-38

Oral Session 8

Challenges faced in detecting silent renal stones: lessons
learnt from the melamine incident of paediatric stones

Metabolic factors and urinary substances
July 20 (Wed)Mayur Danny I Gohel

15:30-16:18

Tung Wah College, Hong Kong

Room 2（2F 201）

O-39

Chairs: Saidakhror S. Kariev(Tashkent State Institute of Postgraduate Medical
Education, Uzbekistan)Management of renal stones in older children with SWL :does general anesthesia have any impact on treatment
outcomes ?

Yasuo Kohjimoto(Wakayama Medical University, Japan)

Murat Tuncer

O-33

Department of Urology, Dr. Lutfi Kirdar Kartal Training andResearch Hospital, Turkey

The urinary kidney stone promoters and inhibitors invarious categories of calcium urolithiasis

O-40

Saidakhror S. Kariev

Ureteroscopic management for ureteral stone inpregnancy using ultrasound without fluoroscopic
monitoring

Tashkent State Institute of Postgraduate Medical Education,
Uzbekistan

O-34

Soichi Mugiya

Hyaluronan is an accidental risk factor for recurrent
calcium oxalate stone formers

Suzukake Central Hospital, Japan

Mayur Danny I Gohel

Oral Session

Tung Wah College, Hong Kong

O-35
Plasma oxalate can be interpreted in relation to GFR todetect the likelihood of primary hyperoxaluria, enteric
hyperoxaluria and common urinary stone disease
John C. Lieske
Mayo Clinic, Rochester, USA

O-36
Relevance of urine calcium and metabolism of urinary
stone
Fazil Y. Marickar
Mount Zion Medical College, India

Oral Session 9
Urolithiasis in pediatrics and pregnant woman
July 22 (Fri)10:00-10:48

Room 1（2F International Conference Room）

Chairs: Mayur Danny I Gohel(Tung Wah College, Hong Kong)

Soichi Mugiya(Suzukake Central Hospital, Japan)

O-37
Renal histopathological features of dent disease, a rare
but important cause of calcium stones to recognize
Xiangling Wang
Mayo Clinic, USA－ 67 －

13th International Symposium on Urolithiasis

Moderated Poster

Moderated Poster 2
Metabolic factors

Moderated Poster 1

July 21 (Thu)

Pathogenesis of stones
July 21 (Thu)

17:26-17:50

Convention Hall A（2F）

16:50-17:20

Convention Hall A（2F）

Chair: Tatsuya Takayama

Chair: Mika Kino
(Funabashi Clinic, Japan)

MP-06(Jichi Medical University, Japan)

Effects of atherosclerosis-related factors on renal crystal
formation in a mouse model of metabolic syndrome

MP-01
Do stone disease and related parameters have any
effect on the physical as well as renal growth of children:
results of a long-term follow-up evaluation
Cahit Sahin

Yasuhiro Fujii
Nagoya City University Graduate School of Medical Sciences, Japan

MP-07
Uric acid stone components is potential risk factor for
renal function deterioration

Departments of Urology and Pediatrics, Dr. Lutfi Kirdar Kartal
Research and Training Hospital, Istanbul, Turkey

Toshikazu Tanaka

MP-02

Department of Urology Hirosaki University School of Medicine,
Hirosaki, Japan

Suppression of cellular damage during acute stage of
CaOx crystal formation by renal tubular cell autophagy

MP-08

Rei Unno
Nagoya City University Graduate School of Medical Sciences, Japan

MP-03

Moderated Poster

Molecular analysis of the glyoxylate/hydroxypyruvate
reductase (GRHPR) gene in Japanese patients withprimary hyperoxaluria type 2
Tatsuya Takayama
Jichi Medical University, Japan

Metabolic syndrome increases the risk for calcium
oxalate stone formation: results from a Nationwide
Survey on Urolithiasis in Japan
Akinori Iba
Wakayama Medical University, Japan

MP-09
Hypocitraturia is much more important thanhypercalciuria

MP-04

Katharina Hauner

Nnt gene suppresses kidney stone formation andoxidative stress

Department of Urology, Rechts der Isar Medical Center, Munich,Germany

Masayuki Usami
Nagoya City University Graduate School of Medical Sciences,
Japan/Sakura General Hospital, Japan

Moderated Poster 3
Inflammation and others

MP-05
Genome wide gene expression profiling of Randall
plaques in calcium oxalate stone formers
Kazumi Taguchi
Department of Nephro-urology, Nagoya City University Graduate
School of Medical Sciences, Japan/Department of Urology,
University of California, San Francisco, USA

July 21 (Thu)

16:50-17:20

Convention Hall A（2F）

Chair: Masaaki Fujimura(Department of Urology, Chibaken Saiseikai Narashino
Hospital, Japan)

MP-10
Oxidative stress, inflammation and sialic acid content inrenal tubular cells exposed to urine from nephrolithiasis
patients and healthy individuals
Chanchai Boonla
Chulalongkorn University, Thailand/Department of Biochemistry,
Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand－ 68 －

ISU2016

MP-11

MP-17

Neutrophil gelatinase-associated lipocalin (NGAL) as abiomarker of renal injury in patients with ureteric stones

Hyperoxaluria induced tubular ischemia: the effects ofverapamil on the antioxidant capacity of the affectedkidneysMarco Bolgeri

Cahit Sahin

University College London Hospital, UK/Darent Valley Hospital, UK

Departments of Urology and Pediatrics, Dr. Lutfi Kirdar Kartal
Research and Training Hospital, Istanbul, Turkey

MP-12Comparison of stone culture using two different
sampling methods (wet and dry)

MP-18
Probability of renal stone formation (PSF) in obese
patients before and after gastric bypass surgery; effectof a preventive strategy

Marco Bolgeri
University College London Hospital, UK

MP-13

Philippe Jaeger

Impacton of ureteral stones into the ureteral wall: is it
possible to predict

University College of London, Centre for Nephrology, London,
UK/Service of Nephrology, Department of Medical Specialties,
University Hospital of Geneva, Switzerland

Cahit Sahin
Departments of Urology and Pediatrics, Dr. Lutfi Kirdar Kartal
Research and Training Hospital, Istanbul, Turkey

MP-19
Silodosin, the selective alpha 1A adrenoceptor
antagonist, facilitates expulsion of size 5 - 10 mm distal
ureteral stones

MP-14
Medical expulsive therapy following SWL in ureteralcalculi: an effective approach for the improvement ofhealth-related quality of life

Yasunori Itoh
Nagoya City University Graduate School of Medical Sciences, Japan

Cahit Sahin
Departments of Urology and Pediatrics, Dr. Lutfi Kirdar Kartal
Research and Training Hospital, Istanbul, Turkey

Moderated Poster 5
July 21 (Thu)Moderated Poster 4
Diagnosis and medical management ofurolithiasis
July 21 (Thu)Chair: Masaki Shimbo(Department of Urology, St. Luke's International Hospital,
Japan)

17:26-17:56

Convention Hall A（2F）

Chair: Yasunori Itoh
(Nagoya City University Graduate School of Medical
Sciences, Japan)

MP-20
The impact of prostatic stones for the procedures ofHolumium-Laser enucleation of prostate
Masaki Shimbo

MP-15
Precise identification of crystal deposits in the kidney
tissueVincent Frochot
Assistance Publique - Hôpitaux de Paris, France

Department of Urology, St. Luke's International Hospital, Japan

MP-21
Endoscopic therapy for pediatric stone disease, ourexperience in more than hundred cases
Florian Kurtz

MP-16
FTIR microspectroscopy is a major diagnostic tool for
2,8-dihydroxyadenine nephropathy
Vincent Frochot
Assistance Publique - Hôpitaux de Paris, France

16:50-17:26

Convention Hall A（2F）

Rechts der Isar, Medical Center, Department of Urology, Technical
University of Munich, Germany

MP-22
New anatomical classification of the pelvicalyceal
system for endoscopic intrarenal surgery
Ryoji Takazawa
Tokyo Metropolitan Ohtsuka Hospital, Japan－ 69 －

Moderated Poster

ESWL and endourology 1/2

13th International Symposium on Urolithiasis

MP-23

MP-30

Efficacy of ESWL training using human body-typed
stone-targeting phantoms

Active stone removal can prevent stone-related deaths
in bedridden patients with upper urinary tract calculi

Atsushi Okada

Shimpei Yamashita

Department of Nephro-urology, Nagoya City University Graduate
School of Medical Sciences, Japan

Wakayama Medical University, Japan

MP-31

MP-24

Risk factors for loss to follow-up in patients with upper
urinary tract stones after surgical treatment

Stone density: probably most important predictive
factor on the stone free rate of endoscopic treatment(RIRS)?

Akinori Iba
Wakayama Medical University, Japan

Igor Romanowsky
Soroka University Hospital, Ben Gurion University, Israel

MP-25
Stone size was the only independent predictor ofresidual stone and multiple procedures of ECIRS
Shimpei Yamashita
Wakayama Medical University, Japan

Moderated Poster 6
ESWL and endourology 2/2
July 21 (Thu)

17:26-18:02

Convention Hall A（2F）

Chair: Iwao Yoshioka(Osaka Police Hospital Urology, Japan)

Moderated Poster

MP-26
Peri-operative outcomes of percutaneous stone surgery
in patients with urinary diversions
Marco Bolgeri
University College London Hospital, UK

MP-27
Can we identify predictors for the risk of embolization
following percutaneous nephrolithotomy?
Marco Bolgeri
University College London Hospital, UK

MP-28
Evaluation of predictive factors for post-operative
pyrexia of transurethral lithotripsy (TUL)
Go Anan
St. Luke's International Hospital, Japan

MP-29
The reasons of inaccuracies admitted in the evaluation of
postoperative complications by Clavien-Dindo grading
system in the endoscopic treatment of urolithiasis
Shukhrat T. Mukhtarov
Republican Specialized Center of Urology, Uzbekistan－ 70 －

ISU2016

FP-07

Free Poster

Toward a new insight of calcium oxalate crystals in fly by
nano-computerized tomography

Free Poster 1

Wen-Chi Chen

Epidemiology and nutrition
July 19 (Tue)China Medical University, Taiwan

17:30-18:30

Convention Hall A（2F）

FP-01

FP-08
Pattern of crystalluria relating to severity of stonediseaseFazil Y. Marickar

Age-related differences in impacts of ambient hot
season on clinical presentation of acute renal colic instone formers

FP-09

Osamu Ichiyanagi

Does stone episode depend on metabolic status?

Mount Zion Medical College, India

Yamagata University Faculty of Medicine, Japan

Fazil Y. Marickar
Mount Zion Medical College, India

FP-02
The correlation between abdominal obesity and stone
analysis in Korean patients

FP-10
Are metabolic changes different in recurrent stone
formers and one time stone formers?

Jea Whan Lee
Wonkwang University Hospital, South Korea

Fazil Y. Marickar
Mount Zion Medical College, India

FP-03
Pregnancy decrease the incidence of stone recurrence infemale patients with urolithiasis
Wen-Chi Chen

Free Poster 3
Crystals and cells

China Medical University, Taiwan/China Medical University
Hospital, Taiwan

July 19 (Tue)

17:30-18:30

Convention Hall A（2F）

FP-04
The role of metabolic abnormalities in stone patients at
different age groups

FP-11

Mount Zion Medical College, India

FP-05

Fernanda T. Borges

Influence of sex in the metabolic parameters of stone
formation

ICAFE, Universidade Cruzeiro do Sul, Brazil/Universidade Federal deSão Paulo, Brazil

Fazil Y. Marickar

FP-12

Mount Zion Medical College, India

Calcium oxalate monohydrate crystals in urinary stone
metabolism
Fazil Y. Marickar

Free Poster 2

Mount Zion Medical College, India

Pathogenesis of stones
July 19 (Tue)

17:30-18:30

Convention Hall A（2F）

FP-13
The presence of calcium oxalate dihydrate crystals andstone metabolism
Fazil Y. Marickar

FP-06
Recovery from nephrotoxicity in rats administered bothmelamine and cyanuric acid
Takahiro Kobayashi
Anjo Kosei Hospital, Japan－ 71 －

Mount Zion Medical College, India

Free Poster

Epithelial to mesenchymal transition (EMT) in vivo andin vitro induced by calcium oxalate (CaOx) and oxalate(Ox)

Fazil Y. Marickar

13th International Symposium on Urolithiasis

FP-14

FP-20

Presence of RBC in urine related to biochemical profileof stone fomers

Evaluation of flavonoids of Ziziphus Lotus L for
antiurolithiatic activitie

Fazil Y. Marickar

Ahmed Bensatal

Mount Zion Medical College, India

Laboratoire de Chimie, Université Zian Achour de Djelfa, Djelfa,
Algeria

FP-15

FP-21

The relevance of pus cells in urine in the metabolism ofurinary stone foirmers

Role of mitochondrial permeability transition in kidneystone formation

Fazil Y. Marickar

Yasuhiko Ito

Mount Zion Medical College, India

Nagoya City University Graduate School of Medical Sciences,
Japan/Holy Spirit Hospital, JapanFree Poster 4
Genetics of stones disease
July 19 (Tue)Free Poster 6
Metabolic factors and stones

17:30-18:30

Convention Hall A（2F）

July 19 (Tue)

17:30-18:30

Convention Hall A（2F）

FP-16
Presence of genetic diversity in Asian and European
cystinuria mutations

FP-22
Cancelled

Shinichi Sakamoto

FP-23

Department of Urology, Chiba University School of Medicine,
Chiba, Japan

Cancelled

FP-24

Free Poster 5
Inhibitors and promoters of stone-formation
July 19 (Tue)A single blind, parallel trial of L-Hydroxyproline inhealthy adult subjects
Saori Akizuki

17:30-18:30

Kyowa Hakko Bio Co., Ltd, Japan

Convention Hall A（2F）

FP-25
FP-17

Free Poster

Inhibitory effect of Rooibos tea on urinary stone
formation in a rat model

Different presentations of stone disease and metabolicstatusFazil Y. Marickar
Mount Zion Medical College, India

Yasuhiko Hirose
Nagoya City University Graduate School of Medical Sciences,
Japan/Anjo Kosei Hospital, Japan

FP-18

FP-26
Urinary oxalate in relation to metabolic parameters instone disease

The effect of green tea for the early period of renal
crystal formation
Masahito Hirose
Konan Kosei Hospital, Japan

FP-19

Fazil Y. Marickar
Mount Zion Medical College, India

FP-27
Role of serum calcium in the metabolism of stone
formation

Febuxostat reduces calcium oxalate monohydrate
crystal-induced upregulation of MCP-1 in MDCK cells

Fazil Y. Marickar
Mount Zion Medical College, India

Dan NakaiKanazawa Medical University, Japan－ 72 －

ISU2016

FP-28

Free Poster 8

Urine uric acid and metabolic profile in urinary stone
formation

Medical management of urolithiasis

Fazil Y. Marickar

July 19 (Tue)Mount Zion Medical College, India

17:30-18:30

Convention Hall A（2F）

FP-29

FP-34

Black stones and white stones the metabolic difference

Changes in renal papillary density after hydration
therapy in calcium stone formers

Fazil Y. Marickar
Mount Zion Medical College, India

Pietro Manuel Ferraro
Catholic University, Rome, Italy

Free Poster 7

FP-35

Diagnosis of urolithiasis
17:30-18:30

Takafumi Minami

Convention Hall A（2F）

FP-30
Microplate method for measurement of urinary
supersaturation to indicate stone reccurence of calcium
oxalateDepartment of Urology, Kinki University School of Medicine, Japan

FP-36
Effect of vitamin D supplementation on urinary calcium
excretion in women with hypercalciuria
Armando L. Negri

Nobuyo Morita

Instituto de Investigaciones Metabolicas Universidad del Salvador,
Argentina

Kanazawa Medical University, Japan

FP-31

FP-37

Can we predict a urinary stone composition by dual
energy analysis of computerized tomography?

Fazil Y. Marickar

Calcium oxalate stone formation can be prevented
Mount Zion Medical College, India

Satoshi Yamaguchi
Department of Urology, Kitasaito Hospital, Japan

FP-38

FP-32

Are diuretics indicated in urinary stone prevention?

Efficacy of duel energy CT on urolithiasis diagnosis andtreatment

Fazil Y. Marickar

Fuminari Hanashima
Saitama Medical University, Japan

Mount Zion Medical College, India

FP-39
Stone clinic effect the missing factor

FP-33
The efficacy of KUB and ultrasonography for thedetection of renal stone
Toru Kanno
Ijinkai Takeda General Hospital, Japan

Fazil Y. Marickar
Mount Zion Medical College, India

FP-40
Role of stone analysis in stone prevention
Fazil Y. Marickar
Mount Zion Medical College, India

FP-41
Problems with citrate therapy
Fazil Y. Marickar
Mount Zion Medical College, India－ 73 －

Free Poster

July 19 (Tue)The clinical role of procalcitonin for urinary tract
infection caused by urinary stone13th International Symposium on Urolithiasis

FP-42

FP-49

Summation effect on stone nucleation a new concept
for prophylaxis

Comparison of percutaneous nephrolithotripsy andretrograde intrarenal surgery for renal stone with adiameter of 20 to 40 mm

Fazil Y. Marickar

Kohsuke Uchida

Mount Zion Medical College, India

Sanjukai Hospital, Japan

FP-50

Free Poster 9
ESWL and endourology
July 19 (Tue)

17:30-18:30

Convention Hall A（2F）

Wideband doppler ultrasound-guided mini-endoscopic
combined intrarenal surgery as an effective and safe
procedure for management of large renal stones: apreliminary report
Takaaki Inoue
Department of Urology and Stone Center, Takii Hospital, Kansai
Medical University, Japan

FP-43
Expectant management and active stone removal for
asymptomatic renal stones

FP-51
Successful removal of a staghorn calculus by miniendoscopic combined intrarenal surgery in a childTakashi Iguchi
Wakayama Medical University, Japan

Teruaki Sugino

FP-44

Department of Nephro-urology, Nagoya City University Graduate
School of Medical Sciences, Japan

Planning of percutaneous nephrolithotomy using three
dimensional computed tomography

FP-52

Shuji Isotani

FP-45

Impact of preoperative stenting to flexible
ureterorenoscope on outcomes and patient quality oflife

Recurrence rate of the upper urinary tract stones

Nobuyo Morita

Juntendo University, Japan

Kanazawa Medical University, Japan

Takuro Masaki
Harasanshin Hospital, Japan

FP-53

FP-46

Effectiveness of preoperative stenting with flexible
ureterorenoscopic lithotripsy for renal stones

Our initial experience of endoscopic combined
intrarenal surgery (ECIRS) in the Galdakao-modified
supine Valdivia position

Shohei Ishida
Department of Urology, Nagoya University Graduate School of
Medicine, JapanFree Poster

Fang-Ching Lee
Toho University Sakura Medical Center, Japan

FP-54

Treatment of upper urinary tract stones over 2cm in sizewith TUL assisted PNL (TAP)The evaluation of urination-related QOL after
ureteroscopic lithotripsy with indwelling the ureteralstent: loop tail stent vs pig tail stent

Yasunobu Hashimoto

Makoto Taguchi

FP-47

Department of Urology and Stone Center, Kansai Medical
University Takii Hospital, Japan/Department of Urology andAndrology, Kansai Medical University Hirakata Hospital, Japan

Saiseikai Kawaguchi General Hospital, Japan/Tokyo Women's
Medical University Aoyama Hospital, Japan

FP-48
A clinical outcome of endoscopic management for
20mm or more of large renal calculi
Mitsunori Matsuo
Kurume University School of Medicine, Japan

FP-55
Relationship between infectious fever and clinicalparameters following percutaneous nephrolithotomy(PNL)
Masaaki Fujimura
Department of Urology, Chibaken Saiseikai Narashino Hospital,Japan－ 74 －

ISU2016

FP-56
Prevention of postoperative high fever of transurethral
lithotripsy after treatment of obstructive pyelonephritis
due to ureteral stone
Genya Nishikawa
Aichi Medical University School of Medicine, Japan

FP-57
Two cases of reduced port laparoscopic pyeloplasty
concomitant with pyelolithotomy
Naoyuki Yamanaka
Department of Urology, Faculty of Medicine, Oita University , Japan

FP-58
Surgical outcomes in laparoscopic lithotomy for upper
urinary tract stones
Kimito Osaka
Yokohama City University Graduate School of Medicine, JapanFree Poster 10
Urolithiasis and inflammation
July 19 (Tue)

17:30-18:30

Convention Hall A（2F）

FP-59
Clinical usefulness of presepsin in obstructive acutepyelonephritis due to upper urinary calculi
Mitsuhiro Tambo
Kyorin University School of Medicine, Japan

FP-60

Taro Murata
Tokyo Metropolitan Police Hospital, Japan

FP-61
Effect of Oxalobacter formigenes colonization on urinary
oxalate excretion
Lama Nazzal
NYU Langone Medical Center, New York, USA

FP-62
Chronic stress and calcium oxalate urolithiasis: are thechanges in urinary risk factors due to stress per se?
Montserrat Arzoz-Fabregas
Hospital Germans Trias I Pujol, Badalona, Spain－ 75 －

Free Poster

Clinical implication of intraoperative stone culture intransurethral ureterolithotripsy

13th International Symposium on Urolithiasis

Luncheon Seminar 1
Androgen Receptor and Stone-CaOx Crystal Formation- Urinary, Prostate, Kidney July 19 (Tue)

12:10-13:10

Room 1（2F International Conference Room）

Chair

Koichiro Akakura
Japan Community Healthcare Organization Tokyo Shinjuku Medical Center, Japan

Speaker

Chawnshang Chang
University of Rochester, Rochester, NY, USA

Janssen Pharmaceutical K.K. / AstraZeneca K.K.

Luncheon Seminar 2*Japanese (Simultaneous translation is available.)

Best Learning Methods for Ureteroscopic Surgery Skills～ New Skill up Simulator ～July 21 (Thu)

12:20-13:20

Room 1（2F International Conference Room）

Chair

Kikuo Nutahara
Kyorin University School of Medicine, Japan

Speaker

Takaaki Inoue
Kansai Medical University, Medical Center, Japan

Luncheon
Seminar

OLYMPUS CORPORATION－ 76 －

ISU2016

Hands-on Seminar
2-1

Flexible URS Hands-on Seminar
July 21 (Thu)

10:30-12:00（2F 202）

Instructors

Thomas Knoll
Department of Urology, Klinikum Sindelfingen-Böblingen, Germany

Yohei Omori
Department of Urology, Tsukuba Medical Center Hospital, Japan

Boston Scientific Japan K.K.

Presidential Seminar
Current status of hormonal therapy for prostate cancer
July 20 (Wed)

12:20-13:20

Room 1（2F International Conference Room）

Tomohiko Ichikawa
Department of Urology, Graduate School of Medicine, Chiba University, Japan

Takeda Pharmaceutical Company Limited.

Hands-on Seminar
Presidential Seminar

Speaker－ 77 －

INDEX13th International Symposium on Urolithiasis

Coordinators/Chairs Index
Coordinator：◎

Chair：＊Ａ

Coordinator/Chair：◎ / ＊Ｍ

Agrawal, Madhu S.

S-05 / ＊Maalouf, Naim M.

Oral Session 3 ＊Arakawa, Takashi

S-04 ,Oral Session 7 ＊Mandel, Neil S.

S-09 / ＊Marickar, Fazil Y.

Oral Session 1 ＊Matsuda, Tadashi

L-01 ＊

Milliner, Dawn S.

S-07 / ＊Miyazawa, Katsuhito

L-11 ＊

Morozumi, Makoto

L-07 ＊ ,Oral Session 2 ＊Mugiya, Soichi

Oral Session 9 ＊◎◎ＢBonny, Olivier

Oral Session 5 ＊Buchholz, Noor

S-01 / ＊◎Ｆ
Fujimura, Masaaki

Moderated Poster 3 ＊ＧGambaro, Giovanni

S-10 / ＊Geavlete, Petrisor

S-04 ＊

Gohel, Mayur Danny I

Oral Session 9 ＊Goldfarb, David S.

S-02 / ＊

◎

◎

◎

Ｎ
Nakatani, Tatsuya

L-05 ＊

Ng, Anthony Cf.

L-13 ＊

Nutahara, Kikuo

L-04 ＊

Ｒ◎

Reis Santos, José M.

Ｈ

S-06 / ＊◎Ｓ

Hara, Isao

S-01 / ＊Hess, Bernhard

L-08 ＊

Holmes, Ross

S-07 / ＊Sarica, Kemal

S-04

Shimbo, Masaki

Moderated Poster 5 ＊ＩSuzuki, Koji

L-03 ＊◎

Sakhaee, Khashayar◎

Ichikawa, Tomohiko

L-02 ＊ ,L-06 ＊Iguchi, Taro

Oral Session 6 ＊Iida, Shizuka

Oral Session 4 ＊Itoh, Yasunori

Moderated Poster 4 ＊ＪJaeger, Philippe

L-10 ＊◎◎/＊,S-06 ＊Ｔ
Takayama, Tatsuya

Moderated Poster 1 ＊Tiselius, Hans-Göran

G-02 ＊

Tozawa, Keiichi

Oral Session 5 ＊Trinchieri, Alberto

S-03 / ＊Tuerk, Christian

G-01 ＊◎Ｗ

Ｋ＊

Kaneko, Kiyoko

Oral Session 3

Kariev, Saidakhror S.

Oral Session 8 ＊Khan, Saeed R.

S-08 / ＊Kino, Mika

Moderated Poster 2 ＊Knudsen, Bodo E.

Oral Session 7 ＊Kohjimoto, Yasuo

Oral Session 8 ＊Kohri, Kenjiro

L-09 ＊

Koide, Takuo

Oral Session 1 ＊Wesson, Jeffrey A.

S-09 / ＊◎Ｙ◎

Yamaguchi, Satoshi

Oral Session 6 ＊Yasui, Takahiro

S-08 / ＊Yoshioka, Iwao

Moderated Poster 6 ＊Ｌ
Letavernier, Emmanuel Oral Session 4 ＊Lieske, John C.

S-03 / ＊Oral Session 2 ＊－ 80 －◎

ISU2016

Authors Index

Ａ

Letavernier, Emmanuel O-06,O-14

Ｈ

Aggarwal, Deepika

O-24

Hamamoto, Shuzo

O-31

Agrawal, Madhu S.

S-05-2,

Hanashima, Fuminari

FP-32

S-05-3

Hashimoto, Yasunobu

FP-47

Akizuki, Saori

FP-24

Hauner, Katharina

MP-09

Anan, Go

MP-28

Hess, Bernhard

S-06-1,O-26

Ando, Ryosuke

O-21

Hirose, Masahito

FP-18

Asplin, John R.

S-02-1Hirose, Yasuhiko

FP-17

Holmes, Ross P.

S-07-1

Arzoz-Fabregas, Montserrat
FP-62
Ather, Hammad M

Iba, Akinori

Maalouf, Naim M.

O-12,O-25

Marickar, Fazil Y.

O-01,O-10,
O-18,O-19,
O-28,O-36,
FP-04,FP-05,
FP-10,FP-12,
FP-13,FP-14,

MP-31
Ichikawa, Tomohiko

L-05

Bolgeri, Marco

MP-11,

Ichiyanagi, Osamu

FP-01

MP-12,

Iguchi, Takashi

FP-43

MP-26,

Iguchi, Taro

O-27

MP-27

Inoue, Takaaki

FP-50

Bonny, Olivier

O-22,O-23

Ishida, Shohei

FP-53

Boonla, Chanchai

S-08-2,Isotani, Shuji

FP-44

MP-10

Ito, Yasuhiko

FP-21

FP-11

Itoh, Yasunori

MP-19

Ｃ

Ｊ

Chaussy, Christian G.

L-01

Chen, Wen-Chi

FP-03,FP-07

Ｅ
O-02

Ｆ
Ferraro, Pietro ManuelS-10-3,FP-34

Frochot, Vincent

MP-15,
MP-16

Fujii, Yasuhiro

MP-06

Fujimura, Masaaki

FP-55

Fukuhara, Hiroki

O-03

Ｇ
Gambaro, Giovanni

S-10-2Geavlete, Petrisor

S-04-02

Gohel, Mayur Danny I

L-13,O-34,
O-38

Goldfarb, David S.

Ｍ

MP-08,

FP-20

Eapen, Paul

O-35

FP-08,FP-09,

Bensatal, Ahmed

Borges, Fernanda T.

O-07,O-11,

Ｉ

S-01-2Ｂ

Lieske, John C.

S-02-3Jaeger, Philippe

MP-18

Ｋ

FP-15,FP-25,
FP-26,FP-27,
FP-28,FP-29,
FP-37,FP-38,
FP-39,FP-40,
FP-41,FP-42
Masaki, Takuro

FP-45

Matsuo, Mitsunori

FP-48

Matsuzaki, Junichi

S-05-1Milliner, Dawn S.

S-07-3

Minami, Takafumi

FP-35

Moe, Orson

S-03-3Morita, Nobuyo

FP-30,FP-52

Mugiya, Soichi

O-40

Mukhtarov, Shukhrat T. MP-29

Kanai, Yoshikatsu

L-06

Kanno, Toru

FP-33

Kariev, Saidakhror S.

O-33

Khan, Saeed R.

L-07,O-05,
O-15

Kino, Mika

O-29

Knoll, Thomas

G-01

Knudsen, Bodo E.

G-02,O-32

Kobayashi, Takahiro

FP-06

Kohjimoto, Yasuo

S-01-3Koul, Hari K.

S-08-1

Kurtz, Florian

MP-21

Murata, TaroＮ
Nakai, Dan

FP-19

Nazzal, Lama

FP-61

Negri, Armando L.

FP-36

Ng, Anthony Cf.

S-01-1

Nishikawa, Genya

FP-56

Ｏ
Okada, Atsushi

S-04-1

Lee, Fang-Ching

FP-46

Lee, Jea Whan

FP-02

－ 81 －

S-08-3,
MP-23

Osaka, Kimito

Ｌ
Lahme, Sven

FP-60

FP-58

Ｒ
Robertson, William G.

L-03

Rodgers, Allen L.

L-09,S-09-3

Romanowsky, Igor

MP-24

Ryall, Rosemary L.

L-11

13th International Symposium on Urolithiasis

Ｓ
Sahin, Cahit

MP-01,
MP-13,
MP-14,
MP-17

Sakamoto, Shinichi

FP-16

Sakhaee, Khashayar

S-03-2

Sarica, Kemal

L-02,S-04-3

Shimbo, Masaki

MP-20

Siener, Roswitha

L-08,S-02-2,
S-07-2

Strohmaier, Walter L.

L-04,O-04,
O-08,O-09,
O-13,O-20

Sugino, Teruaki

FP-51

Ｔ
Taguchi, Kazumi

MP-05

Taguchi, Makoto

FP-54

Takayama, Tatsuya

MP-03

Takazawa, Ryoji

MP-22

Tambo, Mitsuhiro

FP-59

Tanaka, Toshikazu

MP-07

Trinchieri, Alberto

S-03-1Tuncer, Murat

O-39

Ｕ
Uchida, Kohsuke

FP-49

Unno, Rei

MP-02

Usami, Masayuki

MP-04

Ｗ
Wang, Xiangling

O-16,O-37

Wesson, Jeffrey A.

S-09-1,O-17

Williams, James C.

L-10,S-06-3

Ｙ
Yamaguchi, Satoshi

FP-31

Yamanaka, Naoyuki

FP-57

Yamashita, Shimpei

MP-25,
MP-30

Yasui, Takahiro

S-09-2

Yoshino, Yasushi

O-30

Ｚ
Zhong, Wen

S-06-2－ 82 －